14
Taipei 5th Asia-Pacific Osteoporosis Meeting november 14-16, 2014 • Taipei, Chinese Taipei osteoporosis international Volume 25 • Supplement 5
13
final programme www.iofbonehealth.org/taipei-2014
A joint initiative of the International Osteoporosis Foundation and the National Osteoporosis Foundation of the USA
EDITORS-IN-CHIEF John A. Kanis (UK), Robert Lindsay (USA) ASSOCIATE EDITORS C. Cooper (UK), D. W. Dempster (USA), C. C. Glü üer (Germany), S. Jamal (Canada), J. Nieves (USA), E. Seeman (Australia)
REVIEW EDITORS F. Cosman (USA), R. Rizzoli (Switzerland)
MANAGING EDITORS Fina Liu (European Office) Email: [email protected] Adrianne Tewksbury (USA Office) Email: [email protected]
EMERITUS EDITOR-IN-CHIEF P. J. Meunier (France)
EDITORIAL BOARD B. Abrahamsen (Denmark) J. Adachi (Canada) S. Adami (Italy) R. Adler (USA) J.J.B. Anderson (USA) N. Binkley (USA) G. Blake (UK) F. Borgstrom (Sweden) R. Bouillon (Belgium) M.L. Bouxsein (USA) D. Burr (USA) R.D. Chapurlat (France) T. Chevalley (Switzerland) J.E. Compston (UK) R. Cumming (Australia) T. Cundy (New Zealand) E. Dennison (UK) J-P Devogelaer (Belgium) P. Ebeling (Australia) K. Engelke (Germany) E.F. Eriksen (Norway) S.L. Ferrari (Switzerland) J.C. Gallagher (USA) P. Garnero (France) S. Gehlbach (USA) L. Gennari (Italy) P. Geusens (Netherlands)
2
D.T. Gold (USA) S. Gonnelli (Italy) T.N. Hangartner (USA) D. Hanley (Canada) D. Hans (Switzerland) N. Harvey (UK) M. Holick (USA) D.J. Hosking (UK) M. Kassim (UK) M.L. Johnston (USA) G. Jones (Australia) P. Kannus (Finland) S. Khosla (USA) D. Kimmel (USA) M. Kleerekoper (USA) J. Lane (USA) N. Lane (USA) W.D. Leslie (Canada) M.E. Lewiecki (USA) K. Lippuner (Switzerland) P.T. Lips (Netherlands) B. Lukert (USA) K.W. Lyles (USA) J. Magaziner (USA) T. Matsumoto (Japan) L. McCauley (USA) E.V. McCloskey (UK)
M.R. McClung (USA) P.D. Miller (USA) T. Nakamura (Japan) N. Napoli (Italy) T.V. Nguyen (Australia) T. O’Neill (UK) K. Obrant (Sweden) H. Orimo (Japan) S. Papapoulos (Netherlands) M. Pfeifer (Germany) R.J. Phipps (USA) S.D. Rao (USA) F. Rauch (Canada) J.Y. Reginster (Belgium) D. Reid (UK) I.R. Reid (New Zealand) C. Roux (France) S. Shapses (USA) S. Silverman (USA) J. Stepan (Czech Republic) P. Szulc (France) T. Van Staa (UK) P. Vestegaard (Denmark) T. Vokes (USA) N.B. Watts (USA) C. Weaver (USA) J.M. Zmuda (USA)
Table of Contents (as of September 1, 2014 • Subject to change)
1. Congress Organizers Meeting Organization Message from the Meeting Chairs About the International Osteoporosis Foundation (IOF) About the Taiwanese Osteoporosis Association (TOA) - Co-organizer 2. Scientific Programme Programme-at-a-Glance Programme Summary Continuing Medical Education CME Scientific Sessions Information IOF Young Investigator Awards Final Programme 3. Practical Information Venue Map Venue Information Registration Information Social Events 4. Sponsors & Exhibitors Sponsors and Exhibitors Satellite Symposia Programme 5. Abstracts Plenary Lecture Abstracts Oral Communication Abstracts Poster Presentation Abstracts Author Index
S5 S5 S5 S6
5 7 71 8 3 5 3
This supplement was not sponsored by outside commercial interests; it was funded entirely by the society’s own resources.
3
Meeting Organization MEETING CHAIRS Cyrus Cooper, UK Rong-Sen Yang, TWN
MEETING SECRETARIAT International Osteoporosis Foundation (IOF) 9, Rue Juste-Olivier • CH – 1260 Nyon, Switzerland T +41 22 994 0100 • F +41 22 994 0101
LOCAL ORGANIZING COMMITTEe Fang-Ping Chen, Chair, TWN Ding-Cheng Chan, Vice-chair, TWN Ko-En Huang, TWN Jawl-Shan Hwang, TWN
[email protected] www.iofbonehealth.org
SCIENTIFIC PROGRAMME COMMITTEE Cyrus Cooper, Co-chair, uk Rong–Sen Yang, Co-chair, TWN Jung-Fu Chen, TWN Siok-Bee Chionh, SGP Bess Dawson-Hughes, USA Peter Ebeling, AUS Hiroshi Hagino, JPN Andrew Ho, HGK John A. Kanis, UK Joon Kiong Lee, MYS Sarath Lekamwasam, LKA Xu Ling, CHN Zhonghou Liu, CHN Ambrish Mithal, IND Toshitaka Nakamura, JPN Hajime Orimo, JPN Dominique Pierroz, CHE René Rizzoli, CHE Ego Seeman, AUS Satoshi Soen, JPN Keh-Sung Tsai, TWN Chih-Hsing Wu,TWN Yanling Zhao, CHN
www.ticc.com.tw/index_en.aspx
MEETING VENUE Taipei International Convention Centre 1 Hsin-Yi Rd., Sec. 5 • Taipei, Chinese Taipei SPONSORSHIP & EXHIBITION INQUIRIES Asia-Pacific Rhonda Ng / IOF Asia-Pacific Office T +65 6496 5508 • F +65 6496 5599 [email protected]
Global
[email protected]
OFFICIAL CONGRESS ORGANIZING AGENCY MCI Group Asia-Pacific Pte Ltd ON BEHALF OF IOF REGIONALS
#04-02, Cyberhub, 20 Bendemeer Road • Singapore 339914 T +65 6496 5500 • F +65 6496 5599 [email protected]
OFFICIAL REGISTRATION & HOUSING BUREAU MCI Suisse SA ON BEHALF OF IOF REGIONALS 75, rue de Lyon • CH-1211 Geneva 13, Switzerland T +41 22 339 9594 • F +41 22 339 9631 [email protected]
OFFICIAL ABSTRACT HANDLING AGENCY MCI Suisse SA ON BEHALF OF IOF REGIONALS 75, rue de Lyon • CH-1211 Geneva 13, Switzerland T +41 22 339 9676 • F +41 22 339 9601 [email protected]
4
OFFICIAL FREIGHT FORWARDING AGENT Kuehne + Nagel Ltd On behalf of IOF Regionals David Tseng 4F, No. 219, Sec. 3, Nanking East Road,Taipei, Chinese Taipei T +886 2 2544 5114 • F +886 2 8712 6270 [email protected]
Message From the Meeting Chairs Dear Colleagues We wish you a warm welcome to the 2014 IOF Regionals: 5th Asia-Pacific Osteoporosis Meeting. The International Osteoporosis Foundation (IOF) and the Taiwanese Osteoporosis Association (TOA) are proud to host this important scientific meeting in Taipei, with an expected attendance of over 1000 participants from all regions of the world. Over 150 abstracts have been submitted from more than 30 countries. Now in its 5th year, this Meeting once again offers delegates a high-quality programme with renowned international experts as speakers and workshop leaders. There will be 9 plenary sessions and 10 different Meet-the-Expert sessions covering the latest clinical advances in the field. In addition to a wide range of topics related to important clinical aspects of osteoporosis management and fractures, we will also focus on related topics such as bone and diabetes, bariatric surgery and bone, nutrition, osteoporosis in men, orthopaedic trends and secondary fracture prevention. This Meeting is recognized as a top venue for the presentation of new research from the Asia-Pacific (and beyond). We look forward to presenting the latest research in numerous oral and poster presentations. As at previous meetings, we will once again present the ‘IOF Young Investigator Awards’ to the top five ranked abstracts by authors under 40 years of age. With these awards, IOF seeks to encourage and support the work of young and talented researchers in the field. IOF would also like to take this opportunity to thank our industry partners for their support and participation. We encourage delegates to visit the informative exhibition and attend the satellite symposia presented by leading companies in the field. As revealed in the landmark Asia-Pacific Regional Audit published by IOF in December 2013, the region must prepare for an enormous increase in musculoskeletal diseases and fragility fractures. A forum such as the Asia-Pacific Osteoporosis Meeting is an important component in the fight against these diseases. It offers an ideal opportunity to exchange new ideas and information with colleagues from all parts of the world. By learning about new clinical advances and the latest research, delegates will gain valuable insights and knowledge that will directly benefit patient care and fracture prevention. We hope that, in addition to maximizing the educational value of the Meeting, you will also make the most of your stay in Taipei. This city of fascinating contrasts between modern and traditional has a unique multicultural feel and offers unparalleled opportunity for sightseeing, shopping and dining. We wish you an enjoyable and enriching experience.
Cyrus Cooper Co-Chair Scientific Committee
LOC: Local Organizing Committee
Rong-Sen Yang Co-Chair Scientific Committee
Fang-Ping Chen Ding-Cheng Chan chair LOC
vice-chair LOC
5
International Osteoporosis Foundation (IOF) The International Osteoporosis Foundation (IOF) is the only worldwide organization dedicated to the prevention, diagnosis and treatment of osteoporosis and musculoskeletal diseases. It is a Swiss not-for-profit Foundation acting as an umbrella organization bringing together all stakeholders; including, scientists, physicians, patient and medical societies as well as corporate partners interested in osteoporosis, osteoarthritis and bone health. IOF has three membership committees including the Committee of National Societies (CNS) representing 225 member societies in 97 countries or regions, the Committee of Scientific Advisors (CSA) represented by 125 thought leaders from around the world and the Committee of Corporate Advisors (CCA), comprised of 27 companies interested in bone health. In addition, with a new individual membership option, IOF is also extending its outreach to the general public and health professionals around the world. IOF organizes its operations from its headquarters in Nyon, Switzerland, as well as regional offices in Buenos Aires, Dubai and Singapore. It mobilizes the global osteoporosis movement on World Osteoporosis Day October 20, every year. Part of IOF’s mission is to support and enhance the work of its member societies which is reflected in many programmes and projects, including the IOF Worldwide Conference of Osteoporosis Patient Societies, held every two years. IOF holds the annual WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases as well as regional scientific meetings, often in partnership with other organizations. These include the IOF Regionals in the Asia-Pacific, Latin America and the Middle East & Africa regions. Together with the ISCD, IOF also offers an increasingly popular international training course, ‘Osteoporosis: Essentials of Densitometry, Diagnostic and Management’. IOF’s scientific publication portfolio includes the journals Osteoporosis International, Calcified Tissue International and Musculoskeletal Research, Archives of Osteoporosis, and Progress in Osteoporosis, the latter being a free access online review journal which is available at www.iofbonehealth.org/pio. IOF REGIONALIZATION PROGRAMME IOF has a strong regional programme which enhances collaboration among the member associations at the regional level. The programme helps IOF to better serve specific local needs and contributes to the dynamic growth of IOF and the strengthening of osteoporosis associations worldwide. Essential elements of the programme are the ‘IOF Regionals’. These regular regional scientific events help to raise standards of osteoporosis education in the regions and provide an international high-profile forum for local research. They also give many clinicians the opportunity to attend high quality international clinical meetings ‘close to home’. Another important element is the election of Regional Advisory Councils (RAC) from among the full member societies in the regions.
6
9 rue Juste-Olivier • CH-1260 Nyon • Switzerland T +41 22 994 01 00 • F +41 22 994 01 01 [email protected] • www.iofbonehealth.org
MEMBERS OF THE IOF BOARD (as of August 2014)
Jonathan Adachi CAN Gemma Adib SYR John Bilezikian USA Patricia Clark MEX Bess Dawson-Hughes USA (General Secretary) Peter Ebeling AUS Harry Genant USA Stephen Hough zaf John A. Kanis UK (President) Basel Masri JOR Eugene McCloskey UK Osvaldo Daniel Messina ARG Ambrish Mithal IND Hajime Orimo Jpn Socrates Papapoulos Nld Jean-Yves Reginster BEL René Rizzoli che (Treasurer) Ego Seeman AUS Leith Zakraoui TUN José Zanchetta ARG Cristiano Zerbini BRA
Ex-Officio Elected chairs of CNS, CSA, CCA: Cyrus Cooper UK CSA Jean-Yves Reginster BEL CNS Laurence Alliot FRA CCA
Vice Chairs of the CNS, CSA and CCA: Serge Ferrari CHE CSA Glenn Dow USA CCA Famida Jiwa CAN CNS, Patient Societies Subcommittee Chair
IOF Journal Editors
Robert Lindsay USA Editor / Osteoporosis International Stuart Ralston UK Editor / Calcified Tissue International
Regional epidemiological audits – ASIA-PACIFIC AUDIT 2013 IOF has published several landmark reports which collect evidence of the growing burden of osteoporosis around the world and outline the actions that need to be taken to reduce the human and socio-economic costs of the disease in individual countries and across the region. The reports are valuable policy tools which generate media attention while energizing research and health authority outreach in the regions. In 2013 IOF published an update to the ‘Asian Audit’ of 2009.The ‘AsiaPacific Regional Audit: Epidemiology, costs and burden of osteoporosis in 2013’ presents new data and includes information for Australia and New Zealand. In collaboration with the national societies, and sourced from recent literature, the update shines a spotlight on current epidemiological trends in osteoporosis in each of the featured countries. Previous Audits include the ‘Eastern Europe & Central Asia Regional Audit’ (2010), the ‘Middle East & Africa Regional Audit – Epidemiology, costs & burdens of osteoporosis in 2011’, and the ‘Latin America Audit’ (2012). THE asia-pacific REGION IOF counts 33 patient, medical and scientific member societies in 16 countries in the Asia-Pacific region. IOF has appointed Ms. Rhonda Ng ([email protected]) as IOF Asia-Pacific Regional Coordinator. The CNS members in the region elect a Regional Advisory Council: Regional Advisory Council (RAC) for the Asia-Pacific Region Ambrish Mithal Chair IND Suthorn Bavonratanavech THA Siok-Bee Chionh SNG Peter Ebeling AUS Hiroshi Hagino JPN Tai-Pang Ip HKG Sarath Lekamwasam lka Hajime Orimo JPN Ego Seeman AUS
IOF member societies in the AsiaPacific Region
(as of September 2014, listing by alphabetical order of country)
Osteoporosis Australia (OA), AUS Australian and New Zealand Bone And Mineral Society (ANZBMS),AUS China Health Promotion Foundation (CHPF), CHN Osteoporosis Committee of China Gerontological Society (OCCGS), CHn China Osteoporosis Foundation (COF), HKG Hong Kong Osteoporosis Foundation (HKOF), HKG Osteoporosis Society of Hong Kong (OSHK), HKG Arthritis Foundation of India Trust (AFI), IND Indian Rheumatology Association (IRA), IND Osteoporosis Foundation India (OFI), IND Osteoporosis Society of India (OSI), IND The Indian Society for Bone and Mineral Research (ISBMR), IND Indonesian Healthy Bone Foundation (PERWATUSI), IDN Indonesian Osteoporosis Society Perhimpunan Osteoporosis Indonesia (PEROSI), IDN Japan Osteoporosis Foundation (JOF), JPN Japan Osteoporosis Society (JOS), JPN The Japanese Society for Bone and Mineral Research (JSBMR), JPN The Korean Society of Osteoporosis (KSO), KOR The Korean Society of Bone Metabolism (KSBMR), KOR Osteoporosis Awareness Society of Kuala Lumpur (OASKL), MYS Malaysian Osteoporosis Society (MOS), MYS Osteoporosis New Zealand Incorporated (ONZ), NZL Gujranwala Osteoporosis Patient Society (GOPS), PAK Osteoporosis Society of Pakistan (OSP), PAK Pakistan Society for the Rehabilitation of the Disabled (PSRD), PAK Osteoporosis Society of the Philippines Foundation Inc. (OSPFI), PHL Endocrine and Metabolic Society of Singapore (EMSS), SGP Osteoporosis Society (Singapore) (OSS), SGP Osteoporosis Society of Sri Lanka (OSL), LKA Taiwanese Osteoporosis Association (TOA), TWN Asian Pacific Osteoporosis Foundation (APOF), TWN Thai Osteoporosis Foundation (TOPF), THA Vietnam Rheumatology Association (VRA), VNM
7
An inTernATionAl courSe by ioF And iScd
Take part in a comprehensive training course which provides the latest knowledge on densitometry, diagnosis and management of osteoporosis. u Separate tracks for clinicians and technologists. u Available to clinicians and allied health professionals worldwide. u Participants may opt to take a post-course exam in order to attain an Attestation of Achievement. Find out how to host or participate in a course near you. www.osteoporosis-essentials.org
About the Co-organizers Taiwanese Osteoporosis Association The Taiwanese Osteoporosis Association (TOA) was established in 1997 and is comprised of experts who raise awareness of bone health and the prevention of fragility fractures among both health-care professionals and the general public. Members consist of orthopaedic surgeons, gynecologists, endocrinologists, rheumatologists, geriatricians, general internists, family physicians, physiatrists, radiologists and researchers from basic sciences as well as public health. Presidents – rotating from three major disciplines (orthopaedic, Taiwanese Osteoporosis Association gynecology and medicine) – are elected every other year to lead this well [email protected] recognized non-governmental organization (NGO) in the prevention, www.toa1997.org.tw diagnosis and treatment of osteoporosis. TOA has been working hand in hand with the Health Promotion Administration and IOF to achieve mutual missions and goals. Through its annual scientific meeting, educational and certification courses for health professionals, patient health campaigns, as well as media events, TOA has ensured osteoporosis features high on the national health-care agenda. TOA also plays an important role by providing expertise for antiosteoporosis medication indications and reimbursements for the Ministry of Health and Welfare.
9
Programme-at-a-Glance FriDaY nOV 14
SatUrDaY nOV 15
SUnDaY nOV 16
07:00
09:00 10:00 11:00
Meet-the-Expert
Meet-the-Expert
Plenary Session IV with oral abstracts x3
Plenary Session VII with oral abstracts x6
Poster Session I & Exhibition
Poster Session II & Exhibition
Plenary Session I
12:00 13:00
Coffee Break
14:00 15:00
Exhibition
Lunch Industry-sponsored Satellite Symposium
Plenary Session V
Exhibition
08:00
Plenary Session VIII
Lunch Industry-sponsored Satellite Symposium
Lunch Industry-sponsored Satellite Symposium
Plenary Session II with oral abstracts x3
Coffee Break
Coffee Break
Break
Young Investigator Awards Session
Plenary Session IX
Plenary Session III
Poster Viewing & Exhibition
16:00
Close
17:00 Plenary Session VI Opening Ceremony
19:00
Exhibition
18:00
Welcome Reception
20:00
(As of September 1, 2014 • Subject to change)
10
FRAX
®
The Who fracture risk assessment Tool (fraX®) is now easily available on ios & android mobile devices (tablets included), making the calculation tool independent of internet access and simple to use in any clinical setting.
application features
Tool generates the following results (save, delete and
sort options)
(UK users) (version 3.8)
www.shef.ac.uk/fraX/ WWW.iofbonehealTh.org
Programme Summary (As of September 1, 2014 • Subject to change)
Friday November 14, 2014
Friday November 14, 2014
Saturday November 15, 2014
11:00-12:15 Hall 201, Level 2
16:00-17:30 Hall 201, Level 2
9:00-10:30 Hall 201, Level 2
Plenary Session I: Epidemiology
Plenary Session III: Muscle Function and Bone Fragility
Plenary Session IV: Bone and Diabetes
Chairs: A Mithal (IND) & FP Chen (TWN)
Chairs: C Cooper (UK) & KE Huang (TWN)
Epidemiology of Sarcopenia in Asia-Pacific LK Chen (TWN)
Welcome Address PQ Chen (TWN)
Development of Therapeutic Strategies for Muscle Wasting G Krishnan (USA)
How Diabetes Affects Bone S Ferrari (CHE)
Chairs: S Ferrari (CHE) & RS Yang (TWN) Welcome Address Osteoporosis and Burden of Fragility Fractures in Asia KE Huang (TWN) FRAX Uptake in Asia & Worldwide JA Kanis (UK) ®
Mobile DXA in Asia-Pacific Epidemiology Survey BT Kim (KOR) 12:30-13:30 Hall 201, Level 2 Lunch Industry-sponsored Symposium 13:30-14:00 Level 2 Coffee Break 14:00-15:30 Hall 201, Level 2
Plenary Session II: Osteoporosis in Men Chairs: P Ebeling (AUS) & DC Chan (TWN) Osteoporosis in Men: What is Mr Os telling us? E Orwoll (USA) Sex-Specific and Race Difference in Skeletal Fragility E Seeman (AUS) Nutrition and Risk of Hip Fracture in Men: The Singapore Chinese health study WP Koh (SGP) OC1 – Randomized Controlled Trial to Assess the Safety and Efficacy of Odanacatib in the Treatment of Men with Osteoporosis – E Orwoll OC2 – Capture the Fracture: A worldwide initiative for the secondary prevention of osteoporotic fracture – C Cooper OC3 – The Relative Weight of Risk Factor in FRAX® Tool in Taiwan is Different from Other Population – CY Hsu 15:30-16:00 Break
12
Physical Exercise: What, when and how R Daly (AUS)
Epidemiology of Diabetes and its Impact on Bone and Fractures JF Chen (TWN)
Fragility and Fracture Risk in Japan S Ogawa (JPN)
Anti-diabetic Drug Effects on Bone M Chandran (SGP)
17:30-18:30 Hall 201, Level 2 Opening Ceremony
OC4 – Effects of Denosumab on Bone Mineral Density in Postmenopausal Women Transitioning from Raloxifene – KT Yeh
18:30-20:00 Banquet Hall, Level 3 Welcome Reception & Exhibition
Saturday November 15, 2014 8:00-9:00
Meet-the-Expert Session I Prediction of Fracture Risk JA Kanis (UK) Room 101B, Level 1 Alternatives to Bisphosphonates Treatment for Postmenopausal Osteoporosis JK Lee (MLY) Room 101A, Level 1 Vitamin D Status in Asia-Pacific A Mithal (IND) Room 101D, Level 1 New Insight on the Cardiovascular Safety of Strontium Ranelate JY Reginster (BEL) Room 101C, Level 1 Bariatric Surgery and Bone M Chandran (SGP) Room 103, Level 1
OC5 – Odanacatib Anti-fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis: Results from the phase III long-term Odanacatib fracture trial – IR Reid OC6 – Relationship Between FRAX® Score and Falls in Community-dwelling Middle-aged and Old People – LC Ou 10:30-11:15 Banquet hall, Level 3 Poster Session I (P100-P142, P144-P165, P205) Exhibition 11:15-12:45 Hall 201, Level 2
Plenary Session V: What’s new in skeletal therapies? Chairs: E Seeman (AUS) & JK Lee (MLY) An Update on SERM for the Prevention and Treatment of Osteoporosis FP Chen (TWN) Mechanisms of Action and Effects of Cathepsin K Inhibitors S Ferrari (CHE) Mechanisms of Action and Effects of Sclerostin Antibodies KS Tsai (TWN) Algorithm for the Symptomatic and Structural Treatment of Osteoarthritis JY Reginster (BEL)
Saturday November 15, 2014
Sunday November 16, 2014
13:00-14:00 Hall 201, Level 2 Lunch Industry-sponsored Symposium
8:00-9:00
14:00-14:45 Banquet hall, level 3 Coffee Break
Atypical Femoral Fracture RS Yang (TWN) Room 101A, Level 1
14:45-15:45 Hall 201, Level 2
Calcium, Vitamin D & Antiepileptic Drugs SC Shin (KOR) Room 101D, Level 1
Young Investigator Award Session Chairs: R Daly (AUS) & KH Hsu (TWN) OC7 – Quantification of the Heterogeneity of Cortical Porosity and the Effect on Strength – A Zendeli OC8 – Sedentary Time Negates the Positive Influence of Moderate-to-vigorous Physical Activity but Not Vigorous Physical Activity on Bone Strength in Adolescent Girls – VPS Tan OC9 – Projection of Incidence and Economic Burden of Osteoporosis-related Fractures in China: 2010-2050 – L Si OC10 – Association Between Body Weight Change and Risk of Hip Fracture Among Singapore Chinese – Z Dai
Meet-the-Expert Session II
Green Tea Polyphenols for Bone Health CH Wu (TWN) Room 103, Level 1 Guideline for GIO C Cooper (UK) Room 101B, Level 1 Sarcopenia R Rizzoli (CHE) Room 101C, Level 1 9:00-10:30 Hall 201, Level 2
Plenary session VII Chairs: KS Tsai (TWN) & S Vasikaran (AUS) Welcome Address TS Yang (TWN) Best Clinical Papers in 2014 R Rizzoli (CHE)
OC11 – Early Hip Fracture Surgery Reduces Oneyear Mortality and Improves Long-term Survival in Southern Chinese – Y Yip Kan
OC12 – Celiac Disease and Low Femoral Bone Density in a Multiethnic US National Survey – Y Shen
15:45-16:30 Banquet hall, Level 3 Poster Viewing & Exhibition
OC13 – Morbidity as a Risk Factor for Falls in Early Postmenopausal Women According to Type of Fall – N Afrin
16:30-18:00 Hall 201, Level 2
Plenary Session VI: Secondary Fracture prevention Chairs: R Rizzoli (CHE) & S Ogawa (JPN)
OC14 – PQCT Predicted Non-vertebral fracture in Older Non-osteoporotic Men Independently of DXA – T Kwok
Capture the Fracture: Overview C Cooper (UK)
OC15 – The Neglected Health Burden of Non-hip/ Wrist/ Vertebral Fracture (AusICUROS ) – KM Sanders
Orthopaedic Trends in Major Osteoporotic Fractures S Bavonratanavech (THA)
OC16 – Inhibition of P38 MAPK-regulated Pathway Reinforces Treatment Effect of Bisphosphonate – TW Tai
Fracture Liaison Services in Asia-Pacific: Roundtable Chinese Taipei – DC Chan Singapore – M Chandran Japan – H Hagino Malaysia – JK Lee Australia – P Ebeling China – T Sun
OC17 – Effect of Osteophytosis at the Knee on Health-related Quality of Life: A 3-year follow-up of the ROAD study – S Muraki
Sunday November 16, 2014 11:15-12:45 Hall 201, Level 2
Plenary Session VIII: What’s new in Skeletal Assessment? Chairs: S Ferrari (CHE) & LK Chen (TWN) Assessment of Cortical Porosity R Zebaze (AUS) Microstructure Analysis of Bone Strength M Ito (JPN) What is New in Imaging for Fracture Prediction P Ebeling (AUS) Markers of Bone Turnover: What are their clinical use? S Vasikaran (AUS) 13:00-14:00 Hall 201, Level 2 Lunch Industry-sponsored Symposium 14:00-14:45 Banquet hall, level 3 Coffee Break 14:45-16:15 Hall 201, Level 2
Plenary Session IX: Nutrients and Environmental Factors Chairs: CH Wu (TWN) & SC Shin (KOR) Effects of Balance Exercises on Muscle Strength and Bone in Community-living Elderly People WL Hsu (TWN) Dairy and Non-dairy Calcium Effects on Bone R Rizzoli (CHE) Implication of Vitamin E in Bone Metabolism S Takeda (JPN) Community-based Programme KH Hsu (TWN) 16:15 Closing remarks
10:30-11:15 Banquet hall, Level 3 Poster session II (P143, P166-P204, P206-P232) Exhibition
13
WCO-IOF-ESCEO MILAN 2015 W ORLD C ON GRE S S ON OS TE OPORO S IS , OS T E OA RTHRITI S AN D M USC U L OS K E LE TAL D I SE A S E S
MARCH 26-29, 2015 | MILAN ITALY MiCo - Fiera Milano Congressi
www.wco-iof-esceo.org Abstract submission deadline : 15th January 2015
Organized by Sinklar Conference Management B.V.
Scientific Sessions Information MEET-THE-EXPERT SESSIONS Specialists will lead exchanges on ten key topics. Small groups on a “first-come, first-served” pre-registered basis will be encouraged to not only ask questions but to also provide feedback about their own experiences. Saturday November 15, 2014 08:00 – 09:00 Prediction of Fracture Risk – JA Kanis, UK Room 101B Alternatives to Bisphosphonates Treatment for Postmenopausal Osteoporosis – JK Lee, MLY Room 101A Vitamin D Status in Asia-Pacific – A Mithal, IND Room 101D New Insight on the Cardiovascular Safety of Strontium Ranelate – JY Reginster, BEL Room 101C Bariatric Surgery and Bone – M Chandran, SGP Room 103 Sunday November 16, 2014 08:00–09:00 Atypical Femoral Fracture – RS Yang, TWN Room 101A Calcium,Vitamin D and Antiepileptic Drugs – SC Shin, KOR Room 101D Green Tea Polyphenols for Bone Health – CH Wu, TWN Room 103 Guidelines for GIO – C Cooper, GBR Room 101B Sarcopenia – R Rizzoli, CHE Room 101C POSTER PRESENTATION Presenting authors should be present at their posters from 10:30-11:15 according to the following schedule: Poster N°
day assigned
mounting
display
authors present at posters
dismantling
P100 – P142 P144 –P165, P205
Sat. Nov. 15
08:30-09:00
09:00-18:00
10:30-11:15
18:00-18:30
P143, P166 –P204, P206 – P232
Sun. Nov. 16
08:30-09:00
09:00-16:15
10:30-11:15
16:15-17:00
Mounting material will be available at the Poster Help Desk and/or on the poster board Each poster is to be mounted on the poster board according to the number of poster board stated above The Meeting Organizers take no responsibility for posters which are not dismantled on time Poster certificates can be collected from the registration desk upon request SPEAKERS PREVIEW ROOM Location:
Room 203, Level 2
Opening Hours*:
Friday, November 14 08:30 – 17:00 Sunday, November 16 07:00 – 15:30
* subject to change
Saturday, November 15
07:00 – 17:00
Speakers are requested to be at the speakers’ preview room at least 4 hours before their presentations to review, load, and test your presentation Speakers are requested to arrive at the session room at least 15 minutes before the start of their session, in order to meet the chairpersons to discuss the session format European CME Accreditation Application in process. LOCAL CONTINUING MEDICAL EDUCATION (CME) Information coming soon.
15
IOF Young Investigator Award IOF is dedicated to advancing scientific knowledge on osteoporosis, and in particular to encouraging young researchers in all parts of the world to focus on this important area of research. As a sign of this commitment, IOF is offering Young Investigator Awards to the presenting authors (40 years old or younger at the time of the Meeting) of the top five ranking abstracts submitted to the IOF Regionals: 5th Asia-Pacific Osteoporosis Meeting. The recipients are awarded 1 000 USD and are invited to present their work at a special session on Saturday, November 15, 2014 at 14:45-15:45. AWARD RECIPIENTS Afrodite Zendeli, AUS – Quantification of the Heterogeneity of Cortical Porosity and the Effect on Strength Vina PS Tan, CAN – Sedentary Time Negates the Positive Influence of Moderate-to-vigorous Physical Activity but not Vigorous Physical Activity on Bone Strength in Adolescent Girls Lei Si, AUS – Projection of Incidence and Economic Burden of Osteoporosis-related Fractures in China: 2010-2050 Zhaoli Dai, SGP – Association between Body Weight Change and Risk of Hip Fracture among Singapore Chinese Yeung Yip Kan, HKG – Early Hip Fracture Surgery Reduces One-year Mortality and Improves Long-term Survival in Southern Chinese
16
Final Programme (As of September 1, 2014 • Subject to change)
FRIDAY, NOVEMBER 14, 2014 11:00-12:15 PLENARY SESSION I: EPIDEMIOLOGY Hall 201, Level 2 Chairs: S Ferrari (CHE) & RS Yang (TWN) Welcome Address Osteoporosis and Burden of Fragility Fractures in Asia KE Huang (TWN) FRAX® Uptake in Asia and Worldwide JA Kanis (UK) Mobile DXA in Asia Pacific Epidemiology Survey BT Kim (KOR) 12:30-13:30
Lunch Industry-sponsored Symposium
13:30-14:00
Coffee Break
14:00-15:30
PLENARY SESSION II: OSTEOPOROSIS IN MEN Chairs: P Ebeling (AUS) & DC Chan (TWN)
Hall 201, Level 2 Level 2
hall 201, Level 2
Osteoporosis in Men: What is Mr Os telling us? E Orwoll (USA) Sex-specific and Race Difference in Skeletal Fragility E Seeman (AUS) Nutrition and Risk of Hip Fracture in Men: The Singapore Chinese health study WP Koh (SGP) OC1 – Randomized Controlled Trial to Assess the Safety and Efficacy of Odanacatib in the Treatment of Men with Osteoporosis – E Orwoll*, S Adami, N Binkley, R Chapurlat, B Langdahl, S Doleckyj, H Giezek, BB Scott, A Santora OC2 – Capture the Fracture:A worldwide initiative for the secondary prevention of osteoporotic fracture – MK Javaid, C Kyer, PJ Mitchell, C Moss, A McLellan, J Stenmark, DD Pierroz, K Akesson, C Cooper* OC3 – The Relative Weight of Risk Factor in FRAX® Tool in Taiwan is Different from Other Populations – CY Hsu*, JF Chen, WC Chiu, SF Yu, TT Cheng 15:30-16:00 Hall 201, Level 2
Break
17
FRIDAY, NOVEMBER 14, 2014 16:00 - 17:30 PLENARY SESSION III: MUSCLE FUNCTION AND BONE FRAGILITY Hall 201, Level 2 Chairs: A Mithal (IND) and FP Chen (TWN) Epidemiology of Sarcopenia in Asia-Pacific LK Chen (TWN) Development of Therapeutic Strategies for Muscle Wasting G Krishnan (USA) Physical Exercise: What, when and how R Daly (AUS) Fragility and Fracture Risk in Japan S Ogawa (JPN) 17:30-18:30
Opening Ceremony
18:30-20:00
Welcome Reception & Exhibition
Hall 201, Level 2 Banquet hall, Level 3
SATURDAY, NOVEMBER 15, 2014 08:00-09:00 MEET-THE-EXPERT Session i Room 101B, Level 1
Prediction of Fracture Risk JA Kanis (UK)
Room 101A, Level 1
Alternatives to Bisphosphonates Treatment for Postmenopausal Osteoporosis JK Lee (MLY)
Room 101D, Level 1
Vitamin D Status in Asia-Pacific A Mithal (IND)
Room 101C, Level 1
New Insight on the Cardiovascular Safety of Strontium Ranelate JY Reginster (BEL)
Room 103, Level 1
Bariatric Surgery and Bone M Chandran (SGP)
18
SATURDAY, NOVEMBER 15, 2014 PLENARY SESSION IV: BONE AND DIABETES 09:00-10:30 Hall 201, Level 2 Chairs: C Cooper (UK) and KE Huang (TWN) Welcome Address PQ Chen (TWN) How Diabetes affects Bone S Ferrari (CHE) Epidemiology of Diabetes and its Impact on Bone and Fractures JF Chen (TWN) Anti-diabetic Drug Effects on Bone M Chandran (SGP) OC4 – Effects of Denosumab on Bone Mineral Density in Postmenopausal Women Transitioning from Raloxifene – KT Yeh*, WT Wu, CH Thu, JH Wang OC5 – Odanacatib Anti-fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis: Results from the phase III long-term Odanacatib fracture trial – MR McClung, B Langdahl, S Papapoulos, KG Saag, S Adami, HG Bone, T De Villiers, DP Kiel, A Kung, P Kumar, SK Lim, X Ling, K Lippuner, C Mautalen, T Nakamura, JY Reginster, IR Reid*, JA Rodriguez-Portales, C Roux, J Walliser, NB Watts, J Zanchetta, CAF Zerbini, A Rybak-Feiglin, D Cohn, CA DaSilva, R Massaad, A Santora, BB Scott, N Verbuggen, A Leung, A Lombardi OC6 – Relationship Between FRAX® Score and Falls in Community-dwelling Middle-aged and Old People – LC Ou*, CS Chang, YF Chang, TH Chao, RM Lin, ZJ Sun, CH Wu 10:30-11:15
Poster Session I (P100-P142, P144-P165, P205) Exhibition
11:15-12:45
PLENARY SESSION V: WHAT’S NEW IN SKELETAL THERAPIES? Chairs: E Seeman (AUS) and JK Lee (MLY)
Banquet hall, Level 3
Hall 201, Level 2
An Update on SERM for the Prevention and Treatment of Osteoporosis FP Chen (TWN) Mechanisms of Action and Effects of Cathepsin K Inhibitors S Ferrari (CHE) Mechanisms of Action and Effects of Sclerostin Antibodies KS Tsai (TWN) Algorithm for the Symptomatic and Structural Treatment of Osteoarthritis JY Reginster (BEL) 13:00-14:00
Hall 201, Level 2
Lunch Industry-sponsored Symposium
19
SatUrDaY, nOVeMBer 15, 2014 Coffee Break 14:00 -14:45 BAnqUET HALL, LEVEL 3
14:45-15:45
HALL 201, LEVEL 2
iOF YOUng inVeStigatOr aWarD SeSSiOn Chairs: R Daly (AUS) and KH Hsu (TWN) OC7 – Quantification of the Heterogeneity of Cortical Porosity and the Effect on Strength – A Zendeli*, Y Bala, M Kersh, A Gashem-Zadeh, E Seeman, R Zebaze OC8 – Sedentary Time Negates the Positive Influence of Moderate-to-vigorous Physical Activity but not Vigorous Physical Activity on Bone Strength in Adolescent Girls – VPS Tan*, HM Macdonald, HA McKay OC9 – Projection of Incidence and Economic Burden of Osteoporosis-related Fractures in China: 2010-2050 – L Si*, T Winzenberg, Q Jiang, M Chen, A Palmer OC10 – Association Between Body Weight Change and Risk of Hip Fracture Among Singapore Chinese – Z Dai*, LW Ang, WP Koh OC11 – Early Hip Fracture Surgery reduces One-year Mortality and improves Long-term Survival in Southern Chinese – Y Yip Kan*, SH Wong, AW H Ho, ST Ho
15:45-16:30
poster Viewing & exhibition
16:30-18:00
pLenarY SeSSiOn Vi: SeCOnDarY FraCtUre preVentiOn Chairs: R Rizzoli (CHE) & S Ogawa (JPN)
BAnqUET HALL, LEVEL 3
HALL 201, LEVEL 2
Capture the Fracture: Overview C Cooper (UK) Orthopaedic trends in Major Osteoporotic Fractures S Bavonratanavech (THA) Fracture Liaison Services in asia-pacific: roundtable Chinese Taipei – DC Chan Singapore – M Chandran Japan – H Hagino Malaysia – JK Lee Australia – P Ebeling China – T Sun
20
Sunday, nOVeMBer 16, 2014 08:00-09:00 Meet-tHe-eXpert Session ii Room 101A, LEVEL 1
atypical Femoral Fracture RS Yang (TWN)
Room 101D, LEVEL 1
Calcium, Vitamin D and antiepileptic Drugs SC Shin (KOR)
Room 103, LEVEL 1
green tea polyphenols for Bone Health CH Wu (TWN)
Room 101B, LEVEL 1
guideline for giO C Cooper (UK)
Room 101C, LEVEL 1
Sarcopenia R Rizzoli (CHE)
09:00-10:30
pLenarY SeSSiOn Vii Chairs: KS Tsai (TWN) & S Vasikaran (AUS)
HALL 201, LEVEL 2
Welcome address TS Yang (TWN) Best Clinical papers in 2014 R Rizzoli (CHE) OC12 – Celiac Disease and Low Femoral Bone Density in a Multiethnic US National Survey – Y Shen*, M. Wang, D. Martinez OC13 – Morbidity as a Risk Factor for Falls in Early Postmenopausal Women According to Type of Fall – N Afrin*, H Koivumaa-Honkanen, T Rikkonen, H Kröger, R Honkanen OC14 – PQCT Predicted Non-vertebral Fracture in Older Non-osteoporotic Men Independently of DXA – T Kwok* OC15 – The Neglected Health Burden of Non-hip/wrist/vertebral Fracture (AusICUROS) – KM Sanders*, J Abimanyi-Ochom, JJ Watts, GC Nicholson, C Shore-Lorenti, AL Stuart, Y Zhang, S Iluiano, E Seeman, R Prince, L March, M Cross, T Winzenberg, LL Laslett, G Duque, PR Ebeling, F Borgstrom OC16 – Inhibition of P38 MAPK-regulated Pathway Reinforces Treatment Effect of Bisphosphonate – TW Tai*, CY Chen, CF Lin, IM Jou OC17 – Effect of Osteophytosis at the Knee on Health-related Quality of Life. A 3-year Follow-up of the ROAD Study – S Muraki*, T Akune, S Tanaka, H Kawaguchi, K Nakamura, H Oka, N Yoshimura 10:30-11:15 BAnqUET hALL, LEVEL 3
poster session ii (P143, P166-P204, P206-P232) exhibition
21
Sunday, nOVeMBer 16, 2014 pLenarY SeSSiOn Viii: WHat’S neW in SKeLetaL aSSeSSMent? 11:15-12:45 HALL 201, LEVEL 2 Chairs: S Ferrari (CHE) & LK Chen (TWN) assessment of Cortical porosity R Zebaze (AUS) Microstructure analysis of Bone Strength M Ito (JPN) What is new in imaging for Fracture prediction P Ebeling (AUS) Markers of Bone turnover: What are their clinical uses? S Vasikaran (AUS) 13:00-14:00
Lunch industry-sponsored Symposium
14:00 -14:45
Coffee Break
14:45-16:15
pLenarY SeSSiOn iX: nUtrientS anD enVirOnMentaL FaCtOrS Chairs: CH Wu (TWN) & SC Shin (KOR)
HALL 201, LEVEL 2 BAnqUET HALL, LEVEL 3
HALL 201, LEVEL 2
effects of Balance exercises on Muscle Strength and Bone in Community-living elderly people WL Hsu (TWN) Dairy and non-dairy Calcium effects on Bone R Rizzoli (CHE) implication of Vitamin e in Bone Metabolism S Takeda (JPN) Community-based programme KH Hsu (TWN) Closing remarks
22
Level 1
Level 2
MM M
M
M
M
M
MM
MM
101A
M
101D
MM
101B
North Entrance
North Entrance
MM
South Entrance
101C
MM
103
MM
M
M
M
M
M
M
M
MMMM
MMMM
Main Entrance Main Entrance
W
Level 3
N
S
Terrace
E
ROOM NAME
ROOM function
M
M
3 M M
4
M
1 2
Hall 201 Banquet Hall 203 202A 101A-D, 103 202B
5
Plenary Exhibition Posters Meet-the-Expert Speakers Preview Room IOF Office RAC Meeting Room Registration
MM
M
M
M
M
M
6
M
M
to lower level M
M
M
M
MM
Venue Map
Main Entrance
23
Venue & Practical Information Taipei International Convention Centre T www.ticc.com.tw/index_en.aspx
® Google
TOURS AND EXCURSIONS Participants can book local tours by contacting Edison Travel Service, M. Raymond Woon at +886 (0)2 2563 4621 or edisonts@ms6. hinet.net or by visiting the Tours & Excursions desk available by the registration area on November 14, 2014. LUNCH AND REFRESHMENTS Friday, November 14: Lunch symposium by MSD in Hall 201, Level 2. Saturday, November 15: Lunch symposium by GSK in Hall 201, Level 2. Sunday, November 16: Lunch symposium by Pfizer Consumer Healthcare in Hall 201, Level 2. At given time, coffee breaks will be served in Banquet Hall, Level 3, except for Friday, November 14, when it will be served on Level 2. REGISTRATION AND HOTEL HELP DESK The Hotel Help Desk is located within the registration area. EMERGENCY NUMBERS Fire Department & Ambulance: 119 Police Hotline: 110 Any security problems or concerns should be reported to the nearest venue security staff. Security will handle any emergency situation and everyone is asked to follow the instructions announced over the loudspeaker system. Emergency exits are marked with green EXIT signs.
24
SMOKING RESTRICTIONS Smoking is not permitted in indoor areas of all restaurant premises, indoor workplaces, public indoor places and some public outdoor places incl. but not limited to hospitals/clinics, airports, public lifts and toilets, air-conditioned restaurants, public transport, government premises, educational institutions, petrol stations, internet cafes, shopping complexes and private office spaces with central air-conditioning. IOF thanks all participants and exhibitors for not smoking at the Taipei International Convention Centre at all times. INTERNET The Taipei International Conference Center provides complimentary wireless internet access service. WiFi for mobile phones, tablets and laptops is accessible within the Center by selecting the ‘TICC’ signal. LANGUAGE English is the official Meeting language. No translation will not be provided. VISUAL REPRODUCTION POLICY The International Osteoporosis Foundation (IOF) will be photographing and videotaping several of the sessions. If participants wish to take pictures at the sessions, it is strictly forbidden to use flashes. General pictures as well as pictures of the speakers will be available at IOF media outlets. IOF reserves the right to use images (still or moving) captured at this meeting for news outlets (including social media), in promotional material such as future meeting promotions, among others. TRANSPORTATION IN TAIPEI Fast and easy to use, the Taipei Metro (MRT) makes Taipei city one of the easiest Asian capitals to navigate. Every station has bilingual wall maps pointing out the neighborhood’s attractions. In addition to operating the MRT, the Taipei Rapid Transit Association (TRTA) also runs many of Taipei’s public bus routes and private bus lines that crisscross the city. More information is available at http://english.trtc.com.tw/.
25
Registration Information REGISTRATION & HOTEL HELP DESK OPENING HOURS (Subject to change) Friday November 14 08:30-20:00 Saturday November 15 07:30-18:00 Sunday November 16 07:30-16:30 THE DELEGATE REGISTRATION FEE INCLUDES Admission to all Plenary Sessions, Meet-the-Expert Sessions, Satellite Symposia, Poster Sessions and Exhibition Area One copy of the Final Programme & Abstract Book Meeting material and a Meeting badge A Certificate of Attendance Opening Ceremony & Welcome Reception THE ACCOMPANYING PERSON FEE INCLUDES Admission to the Welcome Reception Admission to the Exhibition area NOTE The accompanying person fee does not entitle entrance to any of the scientific sessions or Satellite Symposia.
BADGES All persons attending any function of the Meeting are kindly requested to wear their badges during all Meeting activities including Social Events and Exhibition. Entry will not be permitted without a badge, nor with blank badges or substitute badges. INDIVIDUAL BADGE NAME CHANGES (SUBSTITUTION OF REGISTRATION) & LOST/FORGOTTEN BADGE An administrative fee of USD 55 per badge will be charged for a badge name change (written permission from the original participant will be required, along with full contact details of the substitution) as well as for a lost or forgotten badge (identification card or other recognized identification paper required). CERTIFICATE OF ATTENDANCE AND CME CERTIFICATES Certificates of Attendance and CME will be available on request at the Registration Desks on Saturday November 15, 2014 from 14:00 onwards. Please ensure that you have your badge with you and that your name is correctly written on it. Local Continuing Medical Education (CME) - information coming soon. The certificates will only be handed over against a completed Meeting Evaluation form. REFUND Refunds, when applicable, can only be made after the Meeting. DISCLAIMER The Meeting Organizer (IOF), the Meeting Venue (TICC), its official appointed agencies for Registration & Housing Bureau (MCI Suisse SA) and Local Congress Organizing Agency (MCI Group Asia Pacific Pte Ltd) and any suppliers, representatives or agents linked to the organization of the Meeting shall not be held liable by any person for any injury, damage, theft, loss, medical problem or inconvenience which may be suffered by any person while traveling to or from, or during such person’s presence in Taipei, Chinese Taipei in connection with this Meeting.
26
CANCELLATION, INTERRUPTION OR MODIFICATION OF THE MEETING DUE TO FORCE MAJEURE All reasonable endeavours will be made to hold the Meeting and to present its programme as scheduled under circumstances which assure the comfort and safety of all participants and their guests. However, IOF reserves the right to modify the programme, unilaterally and without notice. In case of force majeure, the Meeting organizers have the right to alter or cancel the Meeting without prior notice, however a notice of the occurrence shall be given by IOF as soon as reasonably possible. Force majeure shall mean any circumstance beyond the reasonable control of IOF which prevents or impedes the holding of the Meeting or continuing it, including, but not limited to, government action, war or hostilities, riot or civil commotion, plague or other epidemic such as SARS, bird flu, etc., earthquake, flood, typhoon, tsunami, cyclone, fire or other natural physical disaster, explosion, accident or breakdown, strike, lack of the usual means of transportation or terrorism or due to events which are not attributable to wrongful intent or gross negligence of the IOF. IOF shall not be liable for any direct or indirect, incidental or consequential damages, losses, expenditures or any other inconveniences or costs caused by such modification, interruption or cancellation of the Meeting. Furthermore, registration fees will not be reimbursed by IOF. Any litigation stemming from the above contract will be tried in Nyon, Switzerland where the Swiss law is exclusively applicable.
27
Social Events Opening Ceremony Friday November 14, 2014 17:30-18:30, Hall 201, Level 2 You are cordially invited to the official Opening Ceremony of the IOF Regionals: 5th Asia-Pacific Osteoporosis Meeting. Professor Shu-Ti Chiou, Director General, Health Promotion Administration, Ministry of Health and Welfare will be our guest of Honour and Mr Sun Yueh, well-known Taiwanese actor will share his perspective on bone health with the audience. The Opening Ceremony will include a traditional Taiwanese cultural presentation to honour the participants and bring good luck to the Meeting. Welcome Reception & Exhibition Opening Friday November 14, 2014 18:30-20:00, Banquet Hall, Level 3 All participants, exhibitors and registered accompanying persons are invited to attend the Welcome Reception, which will follow the Official Opening Ceremony.
28
AbuDhabi‘15 3rd Middle East & Africa Osteoporosis Meeting DeCember 5-7, 2015 • abu Dhabi, uniTeD arab emiraTes
abstract submission opens May 18, 2015 abstract DeaDline August 14, 2015
spons
www.iofbonehealth.org/abudhabi-2015
Sponsors & Exhibitors The IOF Regionals: 5th Asia-Pacific Osteoporosis Meeting organizers would like to thank the sponsors, exhibitors and partners for their support in making this meeting possible: Platinum Sponsor
Gold Sponsor
Bronze Sponsor
CO-ORGANISERS Taiwanese Osteoporosis Association (TOA)
With support from Meet Taiwan
Exhibitors GSK Chugai Pharmaceuticals Co. Ltd
Eli Lilly & Company, Inc Milligrams Instruments Co., Ltd
EXHIBITION OPENING HOURS Friday 14 November 18:00-20:00 Saturday 15 November 09:00-17:30 Sunday 16 November 09:00-15:00
30
GlaxoSmithKline (GSK) GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today’s rapidly changing healthcare environment. GSK’s mission is to improve the quality of human life by enabling people to do more, feel better and live longer. GSK is one of the industry leaders, with an estimated six percent of the world’s pharmaceutical market. GSK’s products and services include pharmamaceuticals (antibiotics, oncology, bone, respiratory, anti-virals, CNS, rare disease, hepatitis B), vaccines and consumer products (analgesics, cough and cold, oral care and personal care, denture care). MSD Today’s MSD is a global healthcare leader working to help the world be well. MSD is known as Merck in the United States and Canada. Through MSD prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, MSD work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrate its commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Pfizer Consumer Healthcare Pfizer Consumer Healthcare (PCH) is a global business unit of Pfizer, Inc., headquartered in Madison, New Jersey, U.S.A. Pfizer Consumer Healthcare’s products include over-the-counter (OTC) medicines, dietary supplements and other products that are top sellers in their categories and household names for consumers around the world. PCH’s major global brands include the world’s #1 ibuprofen analgesic brand, the world’s #1 calcium supplement and the world’s #1 multivitamin. It also markets many other trusted brands for Pain Management, Dietary Supplementation, Respiratory, Gastrointestinal and Personal Care.
31
Satellite Symposia Programme (as of September 3, 2014 – subject to change)
FRIDAY, NOVEMBER 14, 2014 12:30-13:30 Lunch Industry-sponsored Symposium – MSD Hall 201, Level 2
A New Strategy for the Treatment of Osteoporosis Chair: Jung Fu-Chen
Welcome & Introduction Jung Fu-Chen
Significant Need for New Therapies to Treat Osteoporosis Ambrish Mithal
The Role of Cathepsin K in Bone Homeostasis Ego Seeman
Odanacatib: A novel approach to the treatment of osteoporosis Ian Reid
Q & A, Summary and Closing SATURDAY, NOVEMBER 15, 2014 13:00-14:00 Lunch Industry-sponsored Symposium – GlaxoSmithKline (GSK) Hall 201, Level 2
Chair: Rong-Sen Yang
Patient Focused Approach for Long Term Therapy in Postmenopausal Osteoporosis Serge Ferrari & Jung Fu-Chen
Q & A, Summary and Closing SUNDAY, NOVEMBER 16, 2014 13:00-14:00 Lunch Industry-sponsored Symposium – Pfizer Consumer Healthcare (PCH) Hall 201, Level 2
Welcome & Introduction Xiaoyan He
The Risks and Benefits of Calcium and Vitamin D Supplementation for The Prevention of Fracture in Older Women: Results from a collaborative meta-analysis on calcium supplementation and coronary heart disease – understanding the risks and benefits of calcium and vitamin D supplementation Richard Prince
Q & A, Summary and Closing
32
CAPTURE the FRACTURE
IOF
CAPTURE the
FRACTURE
A global campaign facilitating the implementation of Fracture Liaison Services (FLS) for secondary fracture prevention Providing internationally endorsed standards for best practice Facilitating change at a national level Raising awareness among health professionals and the general public
www.capture-the-fracture.org
Taipei 5th Asia-Pacific Osteoporosis Meeting november 14-16, 2014 • Taipei, Chinese Taipei osteoporosis international Volume 25 • Supplement 5
13
final programme www.iofbonehealth.org/taipei-2014
A joint initiative of the International Osteoporosis Foundation and the National Osteoporosis Foundation of the USA
EDITORS-IN-CHIEF John A. Kanis (UK), Robert Lindsay (USA) ASSOCIATE EDITORS C. Cooper (UK), D. W. Dempster (USA), C. C. Glü üer (Germany), S. Jamal (Canada), J. Nieves (USA), E. Seeman (Australia)
REVIEW EDITORS F. Cosman (USA), R. Rizzoli (Switzerland)
MANAGING EDITORS Fina Liu (European Office) Email: [email protected] Adrianne Tewksbury (USA Office) Email: [email protected]
EMERITUS EDITOR-IN-CHIEF P. J. Meunier (France)
EDITORIAL BOARD B. Abrahamsen (Denmark) J. Adachi (Canada) S. Adami (Italy) R. Adler (USA) J.J.B. Anderson (USA) N. Binkley (USA) G. Blake (UK) F. Borgstrom (Sweden) R. Bouillon (Belgium) M.L. Bouxsein (USA) D. Burr (USA) R.D. Chapurlat (France) T. Chevalley (Switzerland) J.E. Compston (UK) R. Cumming (Australia) T. Cundy (New Zealand) E. Dennison (UK) J-P Devogelaer (Belgium) P. Ebeling (Australia) K. Engelke (Germany) E.F. Eriksen (Norway) S.L. Ferrari (Switzerland) J.C. Gallagher (USA) P. Garnero (France) S. Gehlbach (USA) L. Gennari (Italy) P. Geusens (Netherlands)
2
D.T. Gold (USA) S. Gonnelli (Italy) T.N. Hangartner (USA) D. Hanley (Canada) D. Hans (Switzerland) N. Harvey (UK) M. Holick (USA) D.J. Hosking (UK) M. Kassim (UK) M.L. Johnston (USA) G. Jones (Australia) P. Kannus (Finland) S. Khosla (USA) D. Kimmel (USA) M. Kleerekoper (USA) J. Lane (USA) N. Lane (USA) W.D. Leslie (Canada) M.E. Lewiecki (USA) K. Lippuner (Switzerland) P.T. Lips (Netherlands) B. Lukert (USA) K.W. Lyles (USA) J. Magaziner (USA) T. Matsumoto (Japan) L. McCauley (USA) E.V. McCloskey (UK)
M.R. McClung (USA) P.D. Miller (USA) T. Nakamura (Japan) N. Napoli (Italy) T.V. Nguyen (Australia) T. O’Neill (UK) K. Obrant (Sweden) H. Orimo (Japan) S. Papapoulos (Netherlands) M. Pfeifer (Germany) R.J. Phipps (USA) S.D. Rao (USA) F. Rauch (Canada) J.Y. Reginster (Belgium) D. Reid (UK) I.R. Reid (New Zealand) C. Roux (France) S. Shapses (USA) S. Silverman (USA) J. Stepan (Czech Republic) P. Szulc (France) T. Van Staa (UK) P. Vestegaard (Denmark) T. Vokes (USA) N.B. Watts (USA) C. Weaver (USA) J.M. Zmuda (USA)
Table of Contents (as of September 1, 2014 • Subject to change)
1. Congress Organizers Meeting Organization Message from the Meeting Chairs About the International Osteoporosis Foundation (IOF) About the Taiwanese Osteoporosis Association (TOA) - Co-organizer 2. Scientific Programme Programme-at-a-Glance Programme Summary Continuing Medical Education CME Scientific Sessions Information IOF Young Investigator Awards Final Programme 3. Practical Information Venue Map Venue Information Registration Information Social Events 4. Sponsors & Exhibitors Sponsors and Exhibitors Satellite Symposia Programme 5. Abstracts Plenary Lecture Abstracts Oral Communication Abstracts Poster Presentation Abstracts Author Index
S5 S5 S5 S6
5 7 71 8 3 5 3
This supplement was not sponsored by outside commercial interests; it was funded entirely by the society’s own resources.
3
Meeting Organization MEETING CHAIRS Cyrus Cooper, UK Rong-Sen Yang, TWN
MEETING SECRETARIAT International Osteoporosis Foundation (IOF) 9, Rue Juste-Olivier • CH – 1260 Nyon, Switzerland T +41 22 994 0100 • F +41 22 994 0101
LOCAL ORGANIZING COMMITTEe Fang-Ping Chen, Chair, TWN Ding-Cheng Chan, Vice-chair, TWN Ko-En Huang, TWN Jawl-Shan Hwang, TWN
[email protected] www.iofbonehealth.org
SCIENTIFIC PROGRAMME COMMITTEE Cyrus Cooper, Co-chair, uk Rong–Sen Yang, Co-chair, TWN Jung-Fu Chen, TWN Siok-Bee Chionh, SGP Bess Dawson-Hughes, USA Peter Ebeling, AUS Hiroshi Hagino, JPN Andrew Ho, HGK John A. Kanis, UK Joon Kiong Lee, MYS Sarath Lekamwasam, LKA Xu Ling, CHN Zhonghou Liu, CHN Ambrish Mithal, IND Toshitaka Nakamura, JPN Hajime Orimo, JPN Dominique Pierroz, CHE René Rizzoli, CHE Ego Seeman, AUS Satoshi Soen, JPN Keh-Sung Tsai, TWN Chih-Hsing Wu,TWN Yanling Zhao, CHN
www.ticc.com.tw/index_en.aspx
MEETING VENUE Taipei International Convention Centre 1 Hsin-Yi Rd., Sec. 5 • Taipei, Chinese Taipei SPONSORSHIP & EXHIBITION INQUIRIES Asia-Pacific Rhonda Ng / IOF Asia-Pacific Office T +65 6496 5508 • F +65 6496 5599 [email protected]
Global
[email protected]
OFFICIAL CONGRESS ORGANIZING AGENCY MCI Group Asia-Pacific Pte Ltd ON BEHALF OF IOF REGIONALS
#04-02, Cyberhub, 20 Bendemeer Road • Singapore 339914 T +65 6496 5500 • F +65 6496 5599 [email protected]
OFFICIAL REGISTRATION & HOUSING BUREAU MCI Suisse SA ON BEHALF OF IOF REGIONALS 75, rue de Lyon • CH-1211 Geneva 13, Switzerland T +41 22 339 9594 • F +41 22 339 9631 [email protected]
OFFICIAL ABSTRACT HANDLING AGENCY MCI Suisse SA ON BEHALF OF IOF REGIONALS 75, rue de Lyon • CH-1211 Geneva 13, Switzerland T +41 22 339 9676 • F +41 22 339 9601 [email protected]
4
OFFICIAL FREIGHT FORWARDING AGENT Kuehne + Nagel Ltd On behalf of IOF Regionals David Tseng 4F, No. 219, Sec. 3, Nanking East Road,Taipei, Chinese Taipei T +886 2 2544 5114 • F +886 2 8712 6270 [email protected]
Message From the Meeting Chairs Dear Colleagues We wish you a warm welcome to the 2014 IOF Regionals: 5th Asia-Pacific Osteoporosis Meeting. The International Osteoporosis Foundation (IOF) and the Taiwanese Osteoporosis Association (TOA) are proud to host this important scientific meeting in Taipei, with an expected attendance of over 1000 participants from all regions of the world. Over 150 abstracts have been submitted from more than 30 countries. Now in its 5th year, this Meeting once again offers delegates a high-quality programme with renowned international experts as speakers and workshop leaders. There will be 9 plenary sessions and 10 different Meet-the-Expert sessions covering the latest clinical advances in the field. In addition to a wide range of topics related to important clinical aspects of osteoporosis management and fractures, we will also focus on related topics such as bone and diabetes, bariatric surgery and bone, nutrition, osteoporosis in men, orthopaedic trends and secondary fracture prevention. This Meeting is recognized as a top venue for the presentation of new research from the Asia-Pacific (and beyond). We look forward to presenting the latest research in numerous oral and poster presentations. As at previous meetings, we will once again present the ‘IOF Young Investigator Awards’ to the top five ranked abstracts by authors under 40 years of age. With these awards, IOF seeks to encourage and support the work of young and talented researchers in the field. IOF would also like to take this opportunity to thank our industry partners for their support and participation. We encourage delegates to visit the informative exhibition and attend the satellite symposia presented by leading companies in the field. As revealed in the landmark Asia-Pacific Regional Audit published by IOF in December 2013, the region must prepare for an enormous increase in musculoskeletal diseases and fragility fractures. A forum such as the Asia-Pacific Osteoporosis Meeting is an important component in the fight against these diseases. It offers an ideal opportunity to exchange new ideas and information with colleagues from all parts of the world. By learning about new clinical advances and the latest research, delegates will gain valuable insights and knowledge that will directly benefit patient care and fracture prevention. We hope that, in addition to maximizing the educational value of the Meeting, you will also make the most of your stay in Taipei. This city of fascinating contrasts between modern and traditional has a unique multicultural feel and offers unparalleled opportunity for sightseeing, shopping and dining. We wish you an enjoyable and enriching experience.
Cyrus Cooper Co-Chair Scientific Committee
LOC: Local Organizing Committee
Rong-Sen Yang Co-Chair Scientific Committee
Fang-Ping Chen Ding-Cheng Chan chair LOC
vice-chair LOC
5
International Osteoporosis Foundation (IOF) The International Osteoporosis Foundation (IOF) is the only worldwide organization dedicated to the prevention, diagnosis and treatment of osteoporosis and musculoskeletal diseases. It is a Swiss not-for-profit Foundation acting as an umbrella organization bringing together all stakeholders; including, scientists, physicians, patient and medical societies as well as corporate partners interested in osteoporosis, osteoarthritis and bone health. IOF has three membership committees including the Committee of National Societies (CNS) representing 225 member societies in 97 countries or regions, the Committee of Scientific Advisors (CSA) represented by 125 thought leaders from around the world and the Committee of Corporate Advisors (CCA), comprised of 27 companies interested in bone health. In addition, with a new individual membership option, IOF is also extending its outreach to the general public and health professionals around the world. IOF organizes its operations from its headquarters in Nyon, Switzerland, as well as regional offices in Buenos Aires, Dubai and Singapore. It mobilizes the global osteoporosis movement on World Osteoporosis Day October 20, every year. Part of IOF’s mission is to support and enhance the work of its member societies which is reflected in many programmes and projects, including the IOF Worldwide Conference of Osteoporosis Patient Societies, held every two years. IOF holds the annual WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases as well as regional scientific meetings, often in partnership with other organizations. These include the IOF Regionals in the Asia-Pacific, Latin America and the Middle East & Africa regions. Together with the ISCD, IOF also offers an increasingly popular international training course, ‘Osteoporosis: Essentials of Densitometry, Diagnostic and Management’. IOF’s scientific publication portfolio includes the journals Osteoporosis International, Calcified Tissue International and Musculoskeletal Research, Archives of Osteoporosis, and Progress in Osteoporosis, the latter being a free access online review journal which is available at www.iofbonehealth.org/pio. IOF REGIONALIZATION PROGRAMME IOF has a strong regional programme which enhances collaboration among the member associations at the regional level. The programme helps IOF to better serve specific local needs and contributes to the dynamic growth of IOF and the strengthening of osteoporosis associations worldwide. Essential elements of the programme are the ‘IOF Regionals’. These regular regional scientific events help to raise standards of osteoporosis education in the regions and provide an international high-profile forum for local research. They also give many clinicians the opportunity to attend high quality international clinical meetings ‘close to home’. Another important element is the election of Regional Advisory Councils (RAC) from among the full member societies in the regions.
6
9 rue Juste-Olivier • CH-1260 Nyon • Switzerland T +41 22 994 01 00 • F +41 22 994 01 01 [email protected] • www.iofbonehealth.org
MEMBERS OF THE IOF BOARD (as of August 2014)
Jonathan Adachi CAN Gemma Adib SYR John Bilezikian USA Patricia Clark MEX Bess Dawson-Hughes USA (General Secretary) Peter Ebeling AUS Harry Genant USA Stephen Hough zaf John A. Kanis UK (President) Basel Masri JOR Eugene McCloskey UK Osvaldo Daniel Messina ARG Ambrish Mithal IND Hajime Orimo Jpn Socrates Papapoulos Nld Jean-Yves Reginster BEL René Rizzoli che (Treasurer) Ego Seeman AUS Leith Zakraoui TUN José Zanchetta ARG Cristiano Zerbini BRA
Ex-Officio Elected chairs of CNS, CSA, CCA: Cyrus Cooper UK CSA Jean-Yves Reginster BEL CNS Laurence Alliot FRA CCA
Vice Chairs of the CNS, CSA and CCA: Serge Ferrari CHE CSA Glenn Dow USA CCA Famida Jiwa CAN CNS, Patient Societies Subcommittee Chair
IOF Journal Editors
Robert Lindsay USA Editor / Osteoporosis International Stuart Ralston UK Editor / Calcified Tissue International
Regional epidemiological audits – ASIA-PACIFIC AUDIT 2013 IOF has published several landmark reports which collect evidence of the growing burden of osteoporosis around the world and outline the actions that need to be taken to reduce the human and socio-economic costs of the disease in individual countries and across the region. The reports are valuable policy tools which generate media attention while energizing research and health authority outreach in the regions. In 2013 IOF published an update to the ‘Asian Audit’ of 2009.The ‘AsiaPacific Regional Audit: Epidemiology, costs and burden of osteoporosis in 2013’ presents new data and includes information for Australia and New Zealand. In collaboration with the national societies, and sourced from recent literature, the update shines a spotlight on current epidemiological trends in osteoporosis in each of the featured countries. Previous Audits include the ‘Eastern Europe & Central Asia Regional Audit’ (2010), the ‘Middle East & Africa Regional Audit – Epidemiology, costs & burdens of osteoporosis in 2011’, and the ‘Latin America Audit’ (2012). THE asia-pacific REGION IOF counts 33 patient, medical and scientific member societies in 16 countries in the Asia-Pacific region. IOF has appointed Ms. Rhonda Ng ([email protected]) as IOF Asia-Pacific Regional Coordinator. The CNS members in the region elect a Regional Advisory Council: Regional Advisory Council (RAC) for the Asia-Pacific Region Ambrish Mithal Chair IND Suthorn Bavonratanavech THA Siok-Bee Chionh SNG Peter Ebeling AUS Hiroshi Hagino JPN Tai-Pang Ip HKG Sarath Lekamwasam lka Hajime Orimo JPN Ego Seeman AUS
IOF member societies in the AsiaPacific Region
(as of September 2014, listing by alphabetical order of country)
Osteoporosis Australia (OA), AUS Australian and New Zealand Bone And Mineral Society (ANZBMS),AUS China Health Promotion Foundation (CHPF), CHN Osteoporosis Committee of China Gerontological Society (OCCGS), CHn China Osteoporosis Foundation (COF), HKG Hong Kong Osteoporosis Foundation (HKOF), HKG Osteoporosis Society of Hong Kong (OSHK), HKG Arthritis Foundation of India Trust (AFI), IND Indian Rheumatology Association (IRA), IND Osteoporosis Foundation India (OFI), IND Osteoporosis Society of India (OSI), IND The Indian Society for Bone and Mineral Research (ISBMR), IND Indonesian Healthy Bone Foundation (PERWATUSI), IDN Indonesian Osteoporosis Society Perhimpunan Osteoporosis Indonesia (PEROSI), IDN Japan Osteoporosis Foundation (JOF), JPN Japan Osteoporosis Society (JOS), JPN The Japanese Society for Bone and Mineral Research (JSBMR), JPN The Korean Society of Osteoporosis (KSO), KOR The Korean Society of Bone Metabolism (KSBMR), KOR Osteoporosis Awareness Society of Kuala Lumpur (OASKL), MYS Malaysian Osteoporosis Society (MOS), MYS Osteoporosis New Zealand Incorporated (ONZ), NZL Gujranwala Osteoporosis Patient Society (GOPS), PAK Osteoporosis Society of Pakistan (OSP), PAK Pakistan Society for the Rehabilitation of the Disabled (PSRD), PAK Osteoporosis Society of the Philippines Foundation Inc. (OSPFI), PHL Endocrine and Metabolic Society of Singapore (EMSS), SGP Osteoporosis Society (Singapore) (OSS), SGP Osteoporosis Society of Sri Lanka (OSL), LKA Taiwanese Osteoporosis Association (TOA), TWN Asian Pacific Osteoporosis Foundation (APOF), TWN Thai Osteoporosis Foundation (TOPF), THA Vietnam Rheumatology Association (VRA), VNM
7
An inTernATionAl courSe by ioF And iScd
Take part in a comprehensive training course which provides the latest knowledge on densitometry, diagnosis and management of osteoporosis. u Separate tracks for clinicians and technologists. u Available to clinicians and allied health professionals worldwide. u Participants may opt to take a post-course exam in order to attain an Attestation of Achievement. Find out how to host or participate in a course near you. www.osteoporosis-essentials.org
About the Co-organizers Taiwanese Osteoporosis Association The Taiwanese Osteoporosis Association (TOA) was established in 1997 and is comprised of experts who raise awareness of bone health and the prevention of fragility fractures among both health-care professionals and the general public. Members consist of orthopaedic surgeons, gynecologists, endocrinologists, rheumatologists, geriatricians, general internists, family physicians, physiatrists, radiologists and researchers from basic sciences as well as public health. Presidents – rotating from three major disciplines (orthopaedic, Taiwanese Osteoporosis Association gynecology and medicine) – are elected every other year to lead this well [email protected] recognized non-governmental organization (NGO) in the prevention, www.toa1997.org.tw diagnosis and treatment of osteoporosis. TOA has been working hand in hand with the Health Promotion Administration and IOF to achieve mutual missions and goals. Through its annual scientific meeting, educational and certification courses for health professionals, patient health campaigns, as well as media events, TOA has ensured osteoporosis features high on the national health-care agenda. TOA also plays an important role by providing expertise for antiosteoporosis medication indications and reimbursements for the Ministry of Health and Welfare.
9
Programme-at-a-Glance FriDaY nOV 14
SatUrDaY nOV 15
SUnDaY nOV 16
07:00
09:00 10:00 11:00
Meet-the-Expert
Meet-the-Expert
Plenary Session IV with oral abstracts x3
Plenary Session VII with oral abstracts x6
Poster Session I & Exhibition
Poster Session II & Exhibition
Plenary Session I
12:00 13:00
Coffee Break
14:00 15:00
Exhibition
Lunch Industry-sponsored Satellite Symposium
Plenary Session V
Exhibition
08:00
Plenary Session VIII
Lunch Industry-sponsored Satellite Symposium
Lunch Industry-sponsored Satellite Symposium
Plenary Session II with oral abstracts x3
Coffee Break
Coffee Break
Break
Young Investigator Awards Session
Plenary Session IX
Plenary Session III
Poster Viewing & Exhibition
16:00
Close
17:00 Plenary Session VI Opening Ceremony
19:00
Exhibition
18:00
Welcome Reception
20:00
(As of September 1, 2014 • Subject to change)
10
FRAX
®
The Who fracture risk assessment Tool (fraX®) is now easily available on ios & android mobile devices (tablets included), making the calculation tool independent of internet access and simple to use in any clinical setting.
application features
Tool generates the following results (save, delete and
sort options)
(UK users) (version 3.8)
www.shef.ac.uk/fraX/ WWW.iofbonehealTh.org
Programme Summary (As of September 1, 2014 • Subject to change)
Friday November 14, 2014
Friday November 14, 2014
Saturday November 15, 2014
11:00-12:15 Hall 201, Level 2
16:00-17:30 Hall 201, Level 2
9:00-10:30 Hall 201, Level 2
Plenary Session I: Epidemiology
Plenary Session III: Muscle Function and Bone Fragility
Plenary Session IV: Bone and Diabetes
Chairs: A Mithal (IND) & FP Chen (TWN)
Chairs: C Cooper (UK) & KE Huang (TWN)
Epidemiology of Sarcopenia in Asia-Pacific LK Chen (TWN)
Welcome Address PQ Chen (TWN)
Development of Therapeutic Strategies for Muscle Wasting G Krishnan (USA)
How Diabetes Affects Bone S Ferrari (CHE)
Chairs: S Ferrari (CHE) & RS Yang (TWN) Welcome Address Osteoporosis and Burden of Fragility Fractures in Asia KE Huang (TWN) FRAX Uptake in Asia & Worldwide JA Kanis (UK) ®
Mobile DXA in Asia-Pacific Epidemiology Survey BT Kim (KOR) 12:30-13:30 Hall 201, Level 2 Lunch Industry-sponsored Symposium 13:30-14:00 Level 2 Coffee Break 14:00-15:30 Hall 201, Level 2
Plenary Session II: Osteoporosis in Men Chairs: P Ebeling (AUS) & DC Chan (TWN) Osteoporosis in Men: What is Mr Os telling us? E Orwoll (USA) Sex-Specific and Race Difference in Skeletal Fragility E Seeman (AUS) Nutrition and Risk of Hip Fracture in Men: The Singapore Chinese health study WP Koh (SGP) OC1 – Randomized Controlled Trial to Assess the Safety and Efficacy of Odanacatib in the Treatment of Men with Osteoporosis – E Orwoll OC2 – Capture the Fracture: A worldwide initiative for the secondary prevention of osteoporotic fracture – C Cooper OC3 – The Relative Weight of Risk Factor in FRAX® Tool in Taiwan is Different from Other Population – CY Hsu 15:30-16:00 Break
12
Physical Exercise: What, when and how R Daly (AUS)
Epidemiology of Diabetes and its Impact on Bone and Fractures JF Chen (TWN)
Fragility and Fracture Risk in Japan S Ogawa (JPN)
Anti-diabetic Drug Effects on Bone M Chandran (SGP)
17:30-18:30 Hall 201, Level 2 Opening Ceremony
OC4 – Effects of Denosumab on Bone Mineral Density in Postmenopausal Women Transitioning from Raloxifene – KT Yeh
18:30-20:00 Banquet Hall, Level 3 Welcome Reception & Exhibition
Saturday November 15, 2014 8:00-9:00
Meet-the-Expert Session I Prediction of Fracture Risk JA Kanis (UK) Room 101B, Level 1 Alternatives to Bisphosphonates Treatment for Postmenopausal Osteoporosis JK Lee (MLY) Room 101A, Level 1 Vitamin D Status in Asia-Pacific A Mithal (IND) Room 101D, Level 1 New Insight on the Cardiovascular Safety of Strontium Ranelate JY Reginster (BEL) Room 101C, Level 1 Bariatric Surgery and Bone M Chandran (SGP) Room 103, Level 1
OC5 – Odanacatib Anti-fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis: Results from the phase III long-term Odanacatib fracture trial – IR Reid OC6 – Relationship Between FRAX® Score and Falls in Community-dwelling Middle-aged and Old People – LC Ou 10:30-11:15 Banquet hall, Level 3 Poster Session I (P100-P142, P144-P165, P205) Exhibition 11:15-12:45 Hall 201, Level 2
Plenary Session V: What’s new in skeletal therapies? Chairs: E Seeman (AUS) & JK Lee (MLY) An Update on SERM for the Prevention and Treatment of Osteoporosis FP Chen (TWN) Mechanisms of Action and Effects of Cathepsin K Inhibitors S Ferrari (CHE) Mechanisms of Action and Effects of Sclerostin Antibodies KS Tsai (TWN) Algorithm for the Symptomatic and Structural Treatment of Osteoarthritis JY Reginster (BEL)
Saturday November 15, 2014
Sunday November 16, 2014
13:00-14:00 Hall 201, Level 2 Lunch Industry-sponsored Symposium
8:00-9:00
14:00-14:45 Banquet hall, level 3 Coffee Break
Atypical Femoral Fracture RS Yang (TWN) Room 101A, Level 1
14:45-15:45 Hall 201, Level 2
Calcium, Vitamin D & Antiepileptic Drugs SC Shin (KOR) Room 101D, Level 1
Young Investigator Award Session Chairs: R Daly (AUS) & KH Hsu (TWN) OC7 – Quantification of the Heterogeneity of Cortical Porosity and the Effect on Strength – A Zendeli OC8 – Sedentary Time Negates the Positive Influence of Moderate-to-vigorous Physical Activity but Not Vigorous Physical Activity on Bone Strength in Adolescent Girls – VPS Tan OC9 – Projection of Incidence and Economic Burden of Osteoporosis-related Fractures in China: 2010-2050 – L Si OC10 – Association Between Body Weight Change and Risk of Hip Fracture Among Singapore Chinese – Z Dai
Meet-the-Expert Session II
Green Tea Polyphenols for Bone Health CH Wu (TWN) Room 103, Level 1 Guideline for GIO C Cooper (UK) Room 101B, Level 1 Sarcopenia R Rizzoli (CHE) Room 101C, Level 1 9:00-10:30 Hall 201, Level 2
Plenary session VII Chairs: KS Tsai (TWN) & S Vasikaran (AUS) Welcome Address TS Yang (TWN) Best Clinical Papers in 2014 R Rizzoli (CHE)
OC11 – Early Hip Fracture Surgery Reduces Oneyear Mortality and Improves Long-term Survival in Southern Chinese – Y Yip Kan
OC12 – Celiac Disease and Low Femoral Bone Density in a Multiethnic US National Survey – Y Shen
15:45-16:30 Banquet hall, Level 3 Poster Viewing & Exhibition
OC13 – Morbidity as a Risk Factor for Falls in Early Postmenopausal Women According to Type of Fall – N Afrin
16:30-18:00 Hall 201, Level 2
Plenary Session VI: Secondary Fracture prevention Chairs: R Rizzoli (CHE) & S Ogawa (JPN)
OC14 – PQCT Predicted Non-vertebral fracture in Older Non-osteoporotic Men Independently of DXA – T Kwok
Capture the Fracture: Overview C Cooper (UK)
OC15 – The Neglected Health Burden of Non-hip/ Wrist/ Vertebral Fracture (AusICUROS ) – KM Sanders
Orthopaedic Trends in Major Osteoporotic Fractures S Bavonratanavech (THA)
OC16 – Inhibition of P38 MAPK-regulated Pathway Reinforces Treatment Effect of Bisphosphonate – TW Tai
Fracture Liaison Services in Asia-Pacific: Roundtable Chinese Taipei – DC Chan Singapore – M Chandran Japan – H Hagino Malaysia – JK Lee Australia – P Ebeling China – T Sun
OC17 – Effect of Osteophytosis at the Knee on Health-related Quality of Life: A 3-year follow-up of the ROAD study – S Muraki
Sunday November 16, 2014 11:15-12:45 Hall 201, Level 2
Plenary Session VIII: What’s new in Skeletal Assessment? Chairs: S Ferrari (CHE) & LK Chen (TWN) Assessment of Cortical Porosity R Zebaze (AUS) Microstructure Analysis of Bone Strength M Ito (JPN) What is New in Imaging for Fracture Prediction P Ebeling (AUS) Markers of Bone Turnover: What are their clinical use? S Vasikaran (AUS) 13:00-14:00 Hall 201, Level 2 Lunch Industry-sponsored Symposium 14:00-14:45 Banquet hall, level 3 Coffee Break 14:45-16:15 Hall 201, Level 2
Plenary Session IX: Nutrients and Environmental Factors Chairs: CH Wu (TWN) & SC Shin (KOR) Effects of Balance Exercises on Muscle Strength and Bone in Community-living Elderly People WL Hsu (TWN) Dairy and Non-dairy Calcium Effects on Bone R Rizzoli (CHE) Implication of Vitamin E in Bone Metabolism S Takeda (JPN) Community-based Programme KH Hsu (TWN) 16:15 Closing remarks
10:30-11:15 Banquet hall, Level 3 Poster session II (P143, P166-P204, P206-P232) Exhibition
13
WCO-IOF-ESCEO MILAN 2015 W ORLD C ON GRE S S ON OS TE OPORO S IS , OS T E OA RTHRITI S AN D M USC U L OS K E LE TAL D I SE A S E S
MARCH 26-29, 2015 | MILAN ITALY MiCo - Fiera Milano Congressi
www.wco-iof-esceo.org Abstract submission deadline : 15th January 2015
Organized by Sinklar Conference Management B.V.
Scientific Sessions Information MEET-THE-EXPERT SESSIONS Specialists will lead exchanges on ten key topics. Small groups on a “first-come, first-served” pre-registered basis will be encouraged to not only ask questions but to also provide feedback about their own experiences. Saturday November 15, 2014 08:00 – 09:00 Prediction of Fracture Risk – JA Kanis, UK Room 101B Alternatives to Bisphosphonates Treatment for Postmenopausal Osteoporosis – JK Lee, MLY Room 101A Vitamin D Status in Asia-Pacific – A Mithal, IND Room 101D New Insight on the Cardiovascular Safety of Strontium Ranelate – JY Reginster, BEL Room 101C Bariatric Surgery and Bone – M Chandran, SGP Room 103 Sunday November 16, 2014 08:00–09:00 Atypical Femoral Fracture – RS Yang, TWN Room 101A Calcium,Vitamin D and Antiepileptic Drugs – SC Shin, KOR Room 101D Green Tea Polyphenols for Bone Health – CH Wu, TWN Room 103 Guidelines for GIO – C Cooper, GBR Room 101B Sarcopenia – R Rizzoli, CHE Room 101C POSTER PRESENTATION Presenting authors should be present at their posters from 10:30-11:15 according to the following schedule: Poster N°
day assigned
mounting
display
authors present at posters
dismantling
P100 – P142 P144 –P165, P205
Sat. Nov. 15
08:30-09:00
09:00-18:00
10:30-11:15
18:00-18:30
P143, P166 –P204, P206 – P232
Sun. Nov. 16
08:30-09:00
09:00-16:15
10:30-11:15
16:15-17:00
Mounting material will be available at the Poster Help Desk and/or on the poster board Each poster is to be mounted on the poster board according to the number of poster board stated above The Meeting Organizers take no responsibility for posters which are not dismantled on time Poster certificates can be collected from the registration desk upon request SPEAKERS PREVIEW ROOM Location:
Room 203, Level 2
Opening Hours*:
Friday, November 14 08:30 – 17:00 Sunday, November 16 07:00 – 15:30
* subject to change
Saturday, November 15
07:00 – 17:00
Speakers are requested to be at the speakers’ preview room at least 4 hours before their presentations to review, load, and test your presentation Speakers are requested to arrive at the session room at least 15 minutes before the start of their session, in order to meet the chairpersons to discuss the session format European CME Accreditation Application in process. LOCAL CONTINUING MEDICAL EDUCATION (CME) Information coming soon.
15
IOF Young Investigator Award IOF is dedicated to advancing scientific knowledge on osteoporosis, and in particular to encouraging young researchers in all parts of the world to focus on this important area of research. As a sign of this commitment, IOF is offering Young Investigator Awards to the presenting authors (40 years old or younger at the time of the Meeting) of the top five ranking abstracts submitted to the IOF Regionals: 5th Asia-Pacific Osteoporosis Meeting. The recipients are awarded 1 000 USD and are invited to present their work at a special session on Saturday, November 15, 2014 at 14:45-15:45. AWARD RECIPIENTS Afrodite Zendeli, AUS – Quantification of the Heterogeneity of Cortical Porosity and the Effect on Strength Vina PS Tan, CAN – Sedentary Time Negates the Positive Influence of Moderate-to-vigorous Physical Activity but not Vigorous Physical Activity on Bone Strength in Adolescent Girls Lei Si, AUS – Projection of Incidence and Economic Burden of Osteoporosis-related Fractures in China: 2010-2050 Zhaoli Dai, SGP – Association between Body Weight Change and Risk of Hip Fracture among Singapore Chinese Yeung Yip Kan, HKG – Early Hip Fracture Surgery Reduces One-year Mortality and Improves Long-term Survival in Southern Chinese
16
Final Programme (As of September 1, 2014 • Subject to change)
FRIDAY, NOVEMBER 14, 2014 11:00-12:15 PLENARY SESSION I: EPIDEMIOLOGY Hall 201, Level 2 Chairs: S Ferrari (CHE) & RS Yang (TWN) Welcome Address Osteoporosis and Burden of Fragility Fractures in Asia KE Huang (TWN) FRAX® Uptake in Asia and Worldwide JA Kanis (UK) Mobile DXA in Asia Pacific Epidemiology Survey BT Kim (KOR) 12:30-13:30
Lunch Industry-sponsored Symposium
13:30-14:00
Coffee Break
14:00-15:30
PLENARY SESSION II: OSTEOPOROSIS IN MEN Chairs: P Ebeling (AUS) & DC Chan (TWN)
Hall 201, Level 2 Level 2
hall 201, Level 2
Osteoporosis in Men: What is Mr Os telling us? E Orwoll (USA) Sex-specific and Race Difference in Skeletal Fragility E Seeman (AUS) Nutrition and Risk of Hip Fracture in Men: The Singapore Chinese health study WP Koh (SGP) OC1 – Randomized Controlled Trial to Assess the Safety and Efficacy of Odanacatib in the Treatment of Men with Osteoporosis – E Orwoll*, S Adami, N Binkley, R Chapurlat, B Langdahl, S Doleckyj, H Giezek, BB Scott, A Santora OC2 – Capture the Fracture:A worldwide initiative for the secondary prevention of osteoporotic fracture – MK Javaid, C Kyer, PJ Mitchell, C Moss, A McLellan, J Stenmark, DD Pierroz, K Akesson, C Cooper* OC3 – The Relative Weight of Risk Factor in FRAX® Tool in Taiwan is Different from Other Populations – CY Hsu*, JF Chen, WC Chiu, SF Yu, TT Cheng 15:30-16:00 Hall 201, Level 2
Break
17
FRIDAY, NOVEMBER 14, 2014 16:00 - 17:30 PLENARY SESSION III: MUSCLE FUNCTION AND BONE FRAGILITY Hall 201, Level 2 Chairs: A Mithal (IND) and FP Chen (TWN) Epidemiology of Sarcopenia in Asia-Pacific LK Chen (TWN) Development of Therapeutic Strategies for Muscle Wasting G Krishnan (USA) Physical Exercise: What, when and how R Daly (AUS) Fragility and Fracture Risk in Japan S Ogawa (JPN) 17:30-18:30
Opening Ceremony
18:30-20:00
Welcome Reception & Exhibition
Hall 201, Level 2 Banquet hall, Level 3
SATURDAY, NOVEMBER 15, 2014 08:00-09:00 MEET-THE-EXPERT Session i Room 101B, Level 1
Prediction of Fracture Risk JA Kanis (UK)
Room 101A, Level 1
Alternatives to Bisphosphonates Treatment for Postmenopausal Osteoporosis JK Lee (MLY)
Room 101D, Level 1
Vitamin D Status in Asia-Pacific A Mithal (IND)
Room 101C, Level 1
New Insight on the Cardiovascular Safety of Strontium Ranelate JY Reginster (BEL)
Room 103, Level 1
Bariatric Surgery and Bone M Chandran (SGP)
18
SATURDAY, NOVEMBER 15, 2014 PLENARY SESSION IV: BONE AND DIABETES 09:00-10:30 Hall 201, Level 2 Chairs: C Cooper (UK) and KE Huang (TWN) Welcome Address PQ Chen (TWN) How Diabetes affects Bone S Ferrari (CHE) Epidemiology of Diabetes and its Impact on Bone and Fractures JF Chen (TWN) Anti-diabetic Drug Effects on Bone M Chandran (SGP) OC4 – Effects of Denosumab on Bone Mineral Density in Postmenopausal Women Transitioning from Raloxifene – KT Yeh*, WT Wu, CH Thu, JH Wang OC5 – Odanacatib Anti-fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis: Results from the phase III long-term Odanacatib fracture trial – MR McClung, B Langdahl, S Papapoulos, KG Saag, S Adami, HG Bone, T De Villiers, DP Kiel, A Kung, P Kumar, SK Lim, X Ling, K Lippuner, C Mautalen, T Nakamura, JY Reginster, IR Reid*, JA Rodriguez-Portales, C Roux, J Walliser, NB Watts, J Zanchetta, CAF Zerbini, A Rybak-Feiglin, D Cohn, CA DaSilva, R Massaad, A Santora, BB Scott, N Verbuggen, A Leung, A Lombardi OC6 – Relationship Between FRAX® Score and Falls in Community-dwelling Middle-aged and Old People – LC Ou*, CS Chang, YF Chang, TH Chao, RM Lin, ZJ Sun, CH Wu 10:30-11:15
Poster Session I (P100-P142, P144-P165, P205) Exhibition
11:15-12:45
PLENARY SESSION V: WHAT’S NEW IN SKELETAL THERAPIES? Chairs: E Seeman (AUS) and JK Lee (MLY)
Banquet hall, Level 3
Hall 201, Level 2
An Update on SERM for the Prevention and Treatment of Osteoporosis FP Chen (TWN) Mechanisms of Action and Effects of Cathepsin K Inhibitors S Ferrari (CHE) Mechanisms of Action and Effects of Sclerostin Antibodies KS Tsai (TWN) Algorithm for the Symptomatic and Structural Treatment of Osteoarthritis JY Reginster (BEL) 13:00-14:00
Hall 201, Level 2
Lunch Industry-sponsored Symposium
19
SatUrDaY, nOVeMBer 15, 2014 Coffee Break 14:00 -14:45 BAnqUET HALL, LEVEL 3
14:45-15:45
HALL 201, LEVEL 2
iOF YOUng inVeStigatOr aWarD SeSSiOn Chairs: R Daly (AUS) and KH Hsu (TWN) OC7 – Quantification of the Heterogeneity of Cortical Porosity and the Effect on Strength – A Zendeli*, Y Bala, M Kersh, A Gashem-Zadeh, E Seeman, R Zebaze OC8 – Sedentary Time Negates the Positive Influence of Moderate-to-vigorous Physical Activity but not Vigorous Physical Activity on Bone Strength in Adolescent Girls – VPS Tan*, HM Macdonald, HA McKay OC9 – Projection of Incidence and Economic Burden of Osteoporosis-related Fractures in China: 2010-2050 – L Si*, T Winzenberg, Q Jiang, M Chen, A Palmer OC10 – Association Between Body Weight Change and Risk of Hip Fracture Among Singapore Chinese – Z Dai*, LW Ang, WP Koh OC11 – Early Hip Fracture Surgery reduces One-year Mortality and improves Long-term Survival in Southern Chinese – Y Yip Kan*, SH Wong, AW H Ho, ST Ho
15:45-16:30
poster Viewing & exhibition
16:30-18:00
pLenarY SeSSiOn Vi: SeCOnDarY FraCtUre preVentiOn Chairs: R Rizzoli (CHE) & S Ogawa (JPN)
BAnqUET HALL, LEVEL 3
HALL 201, LEVEL 2
Capture the Fracture: Overview C Cooper (UK) Orthopaedic trends in Major Osteoporotic Fractures S Bavonratanavech (THA) Fracture Liaison Services in asia-pacific: roundtable Chinese Taipei – DC Chan Singapore – M Chandran Japan – H Hagino Malaysia – JK Lee Australia – P Ebeling China – T Sun
20
Sunday, nOVeMBer 16, 2014 08:00-09:00 Meet-tHe-eXpert Session ii Room 101A, LEVEL 1
atypical Femoral Fracture RS Yang (TWN)
Room 101D, LEVEL 1
Calcium, Vitamin D and antiepileptic Drugs SC Shin (KOR)
Room 103, LEVEL 1
green tea polyphenols for Bone Health CH Wu (TWN)
Room 101B, LEVEL 1
guideline for giO C Cooper (UK)
Room 101C, LEVEL 1
Sarcopenia R Rizzoli (CHE)
09:00-10:30
pLenarY SeSSiOn Vii Chairs: KS Tsai (TWN) & S Vasikaran (AUS)
HALL 201, LEVEL 2
Welcome address TS Yang (TWN) Best Clinical papers in 2014 R Rizzoli (CHE) OC12 – Celiac Disease and Low Femoral Bone Density in a Multiethnic US National Survey – Y Shen*, M. Wang, D. Martinez OC13 – Morbidity as a Risk Factor for Falls in Early Postmenopausal Women According to Type of Fall – N Afrin*, H Koivumaa-Honkanen, T Rikkonen, H Kröger, R Honkanen OC14 – PQCT Predicted Non-vertebral Fracture in Older Non-osteoporotic Men Independently of DXA – T Kwok* OC15 – The Neglected Health Burden of Non-hip/wrist/vertebral Fracture (AusICUROS) – KM Sanders*, J Abimanyi-Ochom, JJ Watts, GC Nicholson, C Shore-Lorenti, AL Stuart, Y Zhang, S Iluiano, E Seeman, R Prince, L March, M Cross, T Winzenberg, LL Laslett, G Duque, PR Ebeling, F Borgstrom OC16 – Inhibition of P38 MAPK-regulated Pathway Reinforces Treatment Effect of Bisphosphonate – TW Tai*, CY Chen, CF Lin, IM Jou OC17 – Effect of Osteophytosis at the Knee on Health-related Quality of Life. A 3-year Follow-up of the ROAD Study – S Muraki*, T Akune, S Tanaka, H Kawaguchi, K Nakamura, H Oka, N Yoshimura 10:30-11:15 BAnqUET hALL, LEVEL 3
poster session ii (P143, P166-P204, P206-P232) exhibition
21
Sunday, nOVeMBer 16, 2014 pLenarY SeSSiOn Viii: WHat’S neW in SKeLetaL aSSeSSMent? 11:15-12:45 HALL 201, LEVEL 2 Chairs: S Ferrari (CHE) & LK Chen (TWN) assessment of Cortical porosity R Zebaze (AUS) Microstructure analysis of Bone Strength M Ito (JPN) What is new in imaging for Fracture prediction P Ebeling (AUS) Markers of Bone turnover: What are their clinical uses? S Vasikaran (AUS) 13:00-14:00
Lunch industry-sponsored Symposium
14:00 -14:45
Coffee Break
14:45-16:15
pLenarY SeSSiOn iX: nUtrientS anD enVirOnMentaL FaCtOrS Chairs: CH Wu (TWN) & SC Shin (KOR)
HALL 201, LEVEL 2 BAnqUET HALL, LEVEL 3
HALL 201, LEVEL 2
effects of Balance exercises on Muscle Strength and Bone in Community-living elderly people WL Hsu (TWN) Dairy and non-dairy Calcium effects on Bone R Rizzoli (CHE) implication of Vitamin e in Bone Metabolism S Takeda (JPN) Community-based programme KH Hsu (TWN) Closing remarks
22
Level 1
Level 2
MM M
M
M
M
M
MM
MM
101A
M
101D
MM
101B
North Entrance
North Entrance
MM
South Entrance
101C
MM
103
MM
M
M
M
M
M
M
M
MMMM
MMMM
Main Entrance Main Entrance
W
Level 3
N
S
Terrace
E
ROOM NAME
ROOM function
M
M
3 M M
4
M
1 2
Hall 201 Banquet Hall 203 202A 101A-D, 103 202B
5
Plenary Exhibition Posters Meet-the-Expert Speakers Preview Room IOF Office RAC Meeting Room Registration
MM
M
M
M
M
M
6
M
M
to lower level M
M
M
M
MM
Venue Map
Main Entrance
23
Venue & Practical Information Taipei International Convention Centre T www.ticc.com.tw/index_en.aspx
TOURS AND EXCURSIONS Participants can book local tours by contacting Edison Travel Service, M. Raymond Woon at +886 (0)2 2563 4621 or edisonts@ms6. hinet.net or by visiting the Tours & Excursions desk available by the registration area on November 14, 2014. LUNCH AND REFRESHMENTS Friday, November 14: Lunch symposium by MSD in Hall 201, Level 2. Saturday, November 15: Lunch symposium by GSK in Hall 201, Level 2. Sunday, November 16: Lunch symposium by Pfizer Consumer Healthcare in Hall 201, Level 2. At given time, coffee breaks will be served in Banquet Hall, Level 3, except for Friday, November 14, when it will be served on Level 2. REGISTRATION AND HOTEL HELP DESK The Hotel Help Desk is located within the registration area. EMERGENCY NUMBERS Fire Department & Ambulance: 119 Police Hotline: 110 Any security problems or concerns should be reported to the nearest venue security staff. Security will handle any emergency situation and everyone is asked to follow the instructions announced over the loudspeaker system. Emergency exits are marked with green EXIT signs.
24
SMOKING RESTRICTIONS Smoking is not permitted in indoor areas of all restaurant premises, indoor workplaces, public indoor places and some public outdoor places incl. but not limited to hospitals/clinics, airports, public lifts and toilets, air-conditioned restaurants, public transport, government premises, educational institutions, petrol stations, internet cafes, shopping complexes and private office spaces with central air-conditioning. IOF thanks all participants and exhibitors for not smoking at the Taipei International Convention Centre at all times. INTERNET The Taipei International Conference Center provides complimentary wireless internet access service. WiFi for mobile phones, tablets and laptops is accessible within the Center by selecting the ‘TICC’ signal. LANGUAGE English is the official Meeting language. No translation will not be provided. VISUAL REPRODUCTION POLICY The International Osteoporosis Foundation (IOF) will be photographing and videotaping several of the sessions. If participants wish to take pictures at the sessions, it is strictly forbidden to use flashes. General pictures as well as pictures of the speakers will be available at IOF media outlets. IOF reserves the right to use images (still or moving) captured at this meeting for news outlets (including social media), in promotional material such as future meeting promotions, among others. TRANSPORTATION IN TAIPEI Fast and easy to use, the Taipei Metro (MRT) makes Taipei city one of the easiest Asian capitals to navigate. Every station has bilingual wall maps pointing out the neighborhood’s attractions. In addition to operating the MRT, the Taipei Rapid Transit Association (TRTA) also runs many of Taipei’s public bus routes and private bus lines that crisscross the city. More information is available at http://english.trtc.com.tw/.
25
Registration Information REGISTRATION & HOTEL HELP DESK OPENING HOURS (Subject to change) Friday November 14 08:30-20:00 Saturday November 15 07:30-18:00 Sunday November 16 07:30-16:30 THE DELEGATE REGISTRATION FEE INCLUDES Admission to all Plenary Sessions, Meet-the-Expert Sessions, Satellite Symposia, Poster Sessions and Exhibition Area One copy of the Final Programme & Abstract Book Meeting material and a Meeting badge A Certificate of Attendance Opening Ceremony & Welcome Reception THE ACCOMPANYING PERSON FEE INCLUDES Admission to the Welcome Reception Admission to the Exhibition area NOTE The accompanying person fee does not entitle entrance to any of the scientific sessions or Satellite Symposia.
BADGES All persons attending any function of the Meeting are kindly requested to wear their badges during all Meeting activities including Social Events and Exhibition. Entry will not be permitted without a badge, nor with blank badges or substitute badges. INDIVIDUAL BADGE NAME CHANGES (SUBSTITUTION OF REGISTRATION) & LOST/FORGOTTEN BADGE An administrative fee of USD 55 per badge will be charged for a badge name change (written permission from the original participant will be required, along with full contact details of the substitution) as well as for a lost or forgotten badge (identification card or other recognized identification paper required). CERTIFICATE OF ATTENDANCE AND CME CERTIFICATES Certificates of Attendance and CME will be available on request at the Registration Desks on Saturday November 15, 2014 from 14:00 onwards. Please ensure that you have your badge with you and that your name is correctly written on it. Local Continuing Medical Education (CME) - information coming soon. The certificates will only be handed over against a completed Meeting Evaluation form. REFUND Refunds, when applicable, can only be made after the Meeting. DISCLAIMER The Meeting Organizer (IOF), the Meeting Venue (TICC), its official appointed agencies for Registration & Housing Bureau (MCI Suisse SA) and Local Congress Organizing Agency (MCI Group Asia Pacific Pte Ltd) and any suppliers, representatives or agents linked to the organization of the Meeting shall not be held liable by any person for any injury, damage, theft, loss, medical problem or inconvenience which may be suffered by any person while traveling to or from, or during such person’s presence in Taipei, Chinese Taipei in connection with this Meeting.
26
CANCELLATION, INTERRUPTION OR MODIFICATION OF THE MEETING DUE TO FORCE MAJEURE All reasonable endeavours will be made to hold the Meeting and to present its programme as scheduled under circumstances which assure the comfort and safety of all participants and their guests. However, IOF reserves the right to modify the programme, unilaterally and without notice. In case of force majeure, the Meeting organizers have the right to alter or cancel the Meeting without prior notice, however a notice of the occurrence shall be given by IOF as soon as reasonably possible. Force majeure shall mean any circumstance beyond the reasonable control of IOF which prevents or impedes the holding of the Meeting or continuing it, including, but not limited to, government action, war or hostilities, riot or civil commotion, plague or other epidemic such as SARS, bird flu, etc., earthquake, flood, typhoon, tsunami, cyclone, fire or other natural physical disaster, explosion, accident or breakdown, strike, lack of the usual means of transportation or terrorism or due to events which are not attributable to wrongful intent or gross negligence of the IOF. IOF shall not be liable for any direct or indirect, incidental or consequential damages, losses, expenditures or any other inconveniences or costs caused by such modification, interruption or cancellation of the Meeting. Furthermore, registration fees will not be reimbursed by IOF. Any litigation stemming from the above contract will be tried in Nyon, Switzerland where the Swiss law is exclusively applicable.
27
Social Events Opening Ceremony Friday November 14, 2014 17:30-18:30, Hall 201, Level 2 You are cordially invited to the official Opening Ceremony of the IOF Regionals: 5th Asia-Pacific Osteoporosis Meeting. Professor Shu-Ti Chiou, Director General, Health Promotion Administration, Ministry of Health and Welfare will be our guest of Honour and Mr Sun Yueh, well-known Taiwanese actor will share his perspective on bone health with the audience. The Opening Ceremony will include a traditional Taiwanese cultural presentation to honour the participants and bring good luck to the Meeting. Welcome Reception & Exhibition Opening Friday November 14, 2014 18:30-20:00, Banquet Hall, Level 3 All participants, exhibitors and registered accompanying persons are invited to attend the Welcome Reception, which will follow the Official Opening Ceremony.
28
AbuDhabi‘15 3rd Middle East & Africa Osteoporosis Meeting DeCember 5-7, 2015 • abu Dhabi, uniTeD arab emiraTes
abstract submission opens May 18, 2015 abstract DeaDline August 14, 2015
spons
www.iofbonehealth.org/abudhabi-2015
Sponsors & Exhibitors The IOF Regionals: 5th Asia-Pacific Osteoporosis Meeting organizers would like to thank the sponsors, exhibitors and partners for their support in making this meeting possible: Platinum Sponsor
Gold Sponsor
Bronze Sponsor
CO-ORGANISERS Taiwanese Osteoporosis Association (TOA)
With support from Meet Taiwan
Exhibitors GSK Chugai Pharmaceuticals Co. Ltd
Eli Lilly & Company, Inc Milligrams Instruments Co., Ltd
EXHIBITION OPENING HOURS Friday 14 November 18:00-20:00 Saturday 15 November 09:00-17:30 Sunday 16 November 09:00-15:00
30
GlaxoSmithKline (GSK) GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today’s rapidly changing healthcare environment. GSK’s mission is to improve the quality of human life by enabling people to do more, feel better and live longer. GSK is one of the industry leaders, with an estimated six percent of the world’s pharmaceutical market. GSK’s products and services include pharmamaceuticals (antibiotics, oncology, bone, respiratory, anti-virals, CNS, rare disease, hepatitis B), vaccines and consumer products (analgesics, cough and cold, oral care and personal care, denture care). MSD Today’s MSD is a global healthcare leader working to help the world be well. MSD is known as Merck in the United States and Canada. Through MSD prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, MSD work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrate its commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Pfizer Consumer Healthcare Pfizer Consumer Healthcare (PCH) is a global business unit of Pfizer, Inc., headquartered in Madison, New Jersey, U.S.A. Pfizer Consumer Healthcare’s products include over-the-counter (OTC) medicines, dietary supplements and other products that are top sellers in their categories and household names for consumers around the world. PCH’s major global brands include the world’s #1 ibuprofen analgesic brand, the world’s #1 calcium supplement and the world’s #1 multivitamin. It also markets many other trusted brands for Pain Management, Dietary Supplementation, Respiratory, Gastrointestinal and Personal Care.
31
Satellite Symposia Programme (as of September 3, 2014 – subject to change)
FRIDAY, NOVEMBER 14, 2014 12:30-13:30 Lunch Industry-sponsored Symposium – MSD Hall 201, Level 2
A New Strategy for the Treatment of Osteoporosis Chair: Jung Fu-Chen
Welcome & Introduction Jung Fu-Chen
Significant Need for New Therapies to Treat Osteoporosis Ambrish Mithal
The Role of Cathepsin K in Bone Homeostasis Ego Seeman
Odanacatib: A novel approach to the treatment of osteoporosis Ian Reid
Q & A, Summary and Closing SATURDAY, NOVEMBER 15, 2014 13:00-14:00 Lunch Industry-sponsored Symposium – GlaxoSmithKline (GSK) Hall 201, Level 2
Chair: Rong-Sen Yang
Patient Focused Approach for Long Term Therapy in Postmenopausal Osteoporosis Serge Ferrari & Jung Fu-Chen
Q & A, Summary and Closing SUNDAY, NOVEMBER 16, 2014 13:00-14:00 Lunch Industry-sponsored Symposium – Pfizer Consumer Healthcare (PCH) Hall 201, Level 2
Welcome & Introduction Xiaoyan He
The Risks and Benefits of Calcium and Vitamin D Supplementation for The Prevention of Fracture in Older Women: Results from a collaborative meta-analysis on calcium supplementation and coronary heart disease – understanding the risks and benefits of calcium and vitamin D supplementation Richard Prince
Q & A, Summary and Closing
32
CAPTURE the FRACTURE
IOF
CAPTURE the
FRACTURE
A global campaign facilitating the implementation of Fracture Liaison Services (FLS) for secondary fracture prevention Providing internationally endorsed standards for best practice Facilitating change at a national level Raising awareness among health professionals and the general public
www.capture-the-fracture.org
